Endocrine Abstracts

Contents

• Prize Lectures and Biographical Notes
• • The European Journal of Endocrinology Prize Lecture
  • • Insulin Action in Common Disease: Too Much, Too Little, or Both?

      ea0037eje1
    • European Journal of Endocrinology Prize Winner

      ea0037eje1biog
  • The Geoffrey Harris Prize Lecture
  • • Understanding energy sensors, understanding neuroendocrine function

      ea0037gh1
    • Geoffrey Harris Prize Winner

      ea0037gh1biog
• Plenary Lectures
• • PI 3-Kinase: connecting diabetes, obesity and cancer
  • • Abstract unavailable

      ea0037pl1
  • European Hormone Medal Lecture: Obesity and insulin resistance: Lessons from human genetics
  • • Abstract unavailable

      ea0037pl2
  • The genomics of adrenocortical tumors
  • • Abstract unavailable

      ea0037pl3
  • Congenital Adrenal Hyperplasia (CAH): Mechanisms and management across the life span
  • • Overhauling the pathophysiology and treatment of congenital adrenal hyperplasia across the lifetime

      ea0037pl4
  • Insulin signalling and action
  • • Interplay between genes and environment in insulin resistance and metabolic syndrome: the unique role of the gut microbiome

      ea0037pl5
  • Initiative for Science in Europe (ISE) – how can we lobby so that Europe listens?
  • • Abstract unavailable

      ea0037pl6
  • Obesity and the skeleton
  • • Obesity and the skeleton

      ea0037pl7
  • From base change to better care in diabetes
  • • Abstract unavailable

      ea0037pl8
• Symposia
• • Glucocorticoid action in health and disease
  • • Dietary regulation of cortisol production and metabolism in humans

      ea0037s1.1
    • Subclinical Cushing's syndrome and cardiovascular disease

      ea0037s1.2
    • 11β-hydroxysteroid dehydrogenase type 1: substrate promiscuity, implications for local glucocorticoid activation?

      ea0037s1.3
  • Management of type 2 diabetes: State of the art
  • • Blood pressure management in Type 2 Diabetes Mellitus

      ea0037s2.1
    • Blood glucose management

      ea0037s2.2
    • PCSK9 antibodies for the treatment of hypercholesterolemia

      ea0037s2.3
  • Non-classical causes of hypopituitarism (Endorsed by Endocrine Connections)
  • • TBI: whom to screen for hypopituitarism

      ea0037s3.1
    • Genetic causes of hypopituitarism

      ea0037s3.2
    • Drug induced hypopituitarism

      ea0037s3.3
  • Thyroid hormone and cardiovascular system
  • • Subclinical hypothyroidism and cardiovascular consequences in childhood

      ea0037s4.1
    • Cardiovascular impact of thyroid hormone receptor mutations

      ea0037s4.2
    • Cardiovascular actions of novel Thyroid Hormone metabolites

      ea0037s4.3
  • Endocrinology of ageing men
  • • Abstract unavailable

      ea0037s5.1
    • Osteoporosis in ageing men

      ea0037s5.2
    • Abstract unavailable

      ea0037s5.3
  • Beyond Phosphorus: multiple actions of FGF23
  • • FGF23: a cornerstone of phosphate/calcium metabolism

      ea0037s6.1
    • Target cell responses to FGF23

      ea0037s6.2
    • Novel actions of FGF23

      ea0037s6.3
  • Novel mechanisms of central weight regulation
  • • Nutritional regulation of hypothalamic inflammation

      ea0037s7.1
    • Regulation of hypothalamic development by maternal nutrition

      ea0037s7.2
    • Hypothalamic tanycytes in metabolic regulation

      ea0037s7.3
  • The endocrine gut (Endorsed by Endocrine Connections)
  • • Gut microbiota and incretins

      ea0037s8.1
    • Abstract unavailable

      ea0037s8.2
    • Stimulation of incretin secreting cells

      ea0037s8.3
  • Steroid hormone action in target tissues
  • • Tissue-specific sex steroid action: role of HSD17B-enzymes

      ea0037s9.1
    • Steroid sulphatase and colon cancer

      ea0037s9.2
    • Abstract unavailable

      ea0037s9.3
  • Thyroid and autoimmunity
  • • AIRE in thyroid autoimmunity

      ea0037s10.1
    • Dissecting the function of autoimmune regulator (AIRE)

      ea0037s10.2
    • Thyroid, selenium and autoimmunity

      ea0037s10.3
  • Hot topics and IESP symposia
  • • X-linked acro-gigantism (X-LAG): a new form of infant-onset pituitary gigantism

      ea0037s11.1
    • Abstract unavailable

      ea0037s11.2
    • Unimolecular combination therapeutics for the treatment of obesity and type 2 diabetes

      ea0037s11.3
  • Advances in phaeochromocytoma diagnosis and management (Endorsed by the European Journal of Endocrinology)
  • • Update on genetics of phaeochromocytoma/paraganglioma

      ea0037s12.1
    • Current imaging of pheochromocytoma/paraganglioma

      ea0037s12.2
    • Outcome of adrenal sparing surgery in heritable pheochromocytoma: the example of multiple endocrine neoplasia type 2

      ea0037s12.3
  • New concepts in Vitamin D research
  • • Abstract unavailable

      ea0037s13.1
    • Clinical consequences of low vitamin D status

      ea0037s13.2
    • Abstract unavailable

      ea0037s13.3
    • Abstract unavailable

      ea0037s13.4
  • Adipose tissue as an endocrine organ (Endorsed by Endocrine Connections)
  • • Adipose tissue turnover in humans

      ea0037s14.1
    • FGF1 and PPAR-γ in the Adipocyte

      ea0037s14.2
    • Manipulating adipose tissue sensitivity to glucocorticoid excess

      ea0037s14.3
  • Puberty: new mechanisms
  • • Epigenetics of Female Puberty

      ea0037s15.1
    • GnRH development and function: lessons from semaphorins

      ea0037s15.2
    • Genetic regulators of the timing of puberty

      ea0037s15.3
  • Pathogenesis of adrenocortical tumours
  • • Inherited tumour syndromes and adrenal cancer

      ea0037s16.1
    • Role of steroidogenic factor-1 in the pathogenesis of adrenocortical tumours

      ea0037s16.2
    • miRNA as biomarkers in adrenal cancer?

      ea0037s16.3
  • Diabetes and bone (Endorsed by the European Journal of Endocrinology)
  • • Diabetes and osteoporosis -- cause for concern?

      ea0037s17.1
    • Pathophysiology of diabetoporosis

      ea0037s17.2
    • Clinical management of fragile bone in type 2 diabetes

      ea0037s17.3
  • New genetics of pituitary tumours (Endorsed by the European Journal of Endocrinology)
  • • A novel role for stem cells in the regulation of turnover in the postnatal pituitary

      ea0037s18.1
    • Abstract unavailable

      ea0037s18.2
    • Genetics of Cushings Disease

      ea0037s18.3
  • Metabolic dysfunction in PCOS
  • • Genetic determinants of metabolic dysfunction in PCOS

      ea0037s19.1
    • The role of androgens in PCOS-related insulin resistance

      ea0037s19.2
    • Abstract unavailable

      ea0037s19.3
  • Endocrine consequences of childhood cancer treatment
  • • Reproductive function in cancer survivors

      ea0037s20.1
    • Hypopituitarism in cancer survivors

      ea0037s20.2
    • Late effects of cancer treatment on cardiovascular risk

      ea0037s20.3
    • Abstract unavailable

      ea0037s20.4
    • Secondary cancers in childhood cancer survivors

      ea0037s20.5
  • Thyroid hormone in pregnancy
  • • Abstract unavailable

      ea0037s21.1
    • Consequences of maternal thyroid dysfunction for offspring

      ea0037s21.2
    • Thyroid hormone in brain development

      ea0037s21.3
  • Beta cell biology
  • • Noncoding genome function in pancreas development and disease

      ea0037s22.1
    • Novel therapeutic targets in the β-cell

      ea0037s22.2
    • Novel models of human pancreatic beta cells

      ea0037s22.3
  • Adrenal insufficiency: advances in diagnostics and therapy (Endorsed by the European Journal of Endocrinology)
  • • How to diagnose adrenal insufficiency in critical illness?

      ea0037s23.1
    • Regenerative therapy in autoimmune Addison's disease

      ea0037s23.2
    • Cortisol measured in scalp hair as a monitoring tool for systemic cortisol levels

      ea0037s23.3
  • Androgens and disease progression in prostate cancer
  • • Leveraging circulating DNA studies to identify mechanisms of resistance to CYP17A1 inhibition

      ea0037s24.1
    • Abstract unavailable

      ea0037s24.2
    • Abstract unavailable

      ea0037s24.3
  • Challenges in pituitary tumours
  • • Treatment with temozolomide in aggressive pituitary tumours with or without metastases

      ea0037s25.1
    • Abstract unavailable

      ea0037s25.2
    • Abstract unavailable

      ea0037s25.3
  • Towards the bionic pancreas: will the journey end?
  • • Abstract unavailable

      ea0037s26.1
    • Continuous glucose monitoring systems

      ea0037s26.2
    • Artificial Pancreas

      ea0037s26.3
  • Thyroid cancer: new development in diagnosis and treatment (Endorsed by the European Journal of Endocrinology)
  • • Central neck dissection: an important step forward in the management of thyroid papillary cancer

      ea0037s27.1
    • Abstract unavailable

      ea0037s27.2
    • Abstract unavailable

      ea0037s27.3
  • Hormones and immunity in pregnancy
  • • Hormonal modulation of immune responses during pregnancy

      ea0037s28.1
    • Sex hormones and B cells in pregnancy

      ea0037s28.2
    • Vitamin D and pregnancy outcome

      ea0037s28.3
  • Management of endocrine transition
  • • Abstract unavailable

      ea0037s29.1
    • Management of endocrine transition

      ea0037s29.2
    • GH deficiency: the transition from childhood/adolescence to adulthood

      ea0037s29.3
    • Prader--Willi syndrome

      ea0037s29.4
    • Management of endocrine transition: type 1 diabetes

      ea0037s29.5
• Debate
• • How to manage hyponatraemia according to guidelines?
  • • Abstract unavailable

      ea0037d1.1
    • How to manage hyponatraemia according to guidelines? The USA perspective

      ea0037d1.2
• Meet the Expert Sessions
• • (1)
  • • Abstract unavailable

      ea0037mte1
    • Management of prolactinoma

      ea0037mte2
    • Abstract unavailable

      ea0037mte3
    • Management of thyroid eye disease

      ea0037mte4
    • Central precocious puberty: management and long-term outcome

      ea0037mte5
    • Management of the transgender patient

      ea0037mte6
    • Management of adrenal insufficiency

      ea0037mte7
    • Acromegaly and cancer

      ea0037mte8
    • Management of craniopharyngioma

      ea0037mte9
    • Approach to the patient with dyslipidaemia

      ea0037mte10
    • MTE 13: management of male osteoporosis

      ea0037mte11
    • Medullary thyroid cancer

      ea0037mte12
    • Abstract unavailable

      ea0037mte13
    • Meet the expert 17 (MTE17): management of Turner syndrome

      ea0037mte14
    • Primary hyperparathyroidism (Meet-the-Expert 18)

      ea0037mte15
    • Assessing osteoporosis in the young adult

      ea0037mte16
    • Abstract unavailable

      ea0037mte17
• Educational Workshop
• • Practical publishing advice
  • • Abstract unavailable

      ea0037ew1.1
    • The peer review process

      ea0037ew1.2
    • Publishing ethics: fabrication, falsification and plagiarism

      ea0037ew1.3
    • Responding to reviewer comments

      ea0037ew1.4
    • Open access

      ea0037ew1.5
    • Abstract unavailable

      ea0037ew1.6
• European Young Endocrinologists
• • Sex, drugs and rocking hormones
  • • Abstract unavailable

      ea0037eyes1.1
    • Abstract unavailable

      ea0037eyes1.2
    • Drug addiction and the endocannabinoid system

      ea0037eyes1.3
    • Hypothalamo-pituitary-adrenal axis response and adaptation to repeated physical stress in professional athletes

      ea0037eyes1.4
    • Abstract unavailable

      ea0037eyes1.5
    • Abstract unavailable

      ea0037eyes1.6
• Endocrine Nursing
• • The journey of the patient with obesity: multidisciplinary care approach
  • • Abstract unavailable

      ea0037en1.1
    • Why bariatric surgery should be considered as an option for obese patients

      ea0037en1.2
    • Abstract unavailable

      ea0037en1.3
  • Professional development, poster presentations and networking
  • • Abstract unavailable

      ea0037en2.1
    • Challenges in diagnosis, treating and managing patients presenting with hyponatraemia, polydipsia and polyuria: implications for nursing practice

      ea0037en2.2
    • Developing an effective abstract and poster presentation

      ea0037en2.3
    • Research topic: identifying the needs of patients with Congenital Hypogonadotrophic Hypogonadism, implications for nursing practice

      ea0037en2.4
    • Abstract unavailable

      ea0037en2.5
    • Abstract unavailable

      ea0037en2.6
  • Meet the Nurse Expert
  • • Pre- and post-operative approaches for a patient with pheochromocytoma/paraganglioma

      ea0037en3.1
    • Abstract unavailable

      ea0037en3.2
    • Abstract unavailable

      ea0037en3.3
• Oral Communications
• • Adrenal 1
  • • PRKACA defects and cortisol-producing lesions of the adrenal cortex: specific clinical phenotypes and histological features

      ea0037oc1.1
    • Functional study of ARMC5 (armadillo repeat containing 5), a new tumour suppressor gene involved in primary bilateral macronodular adrenal hyperplasia

      ea0037oc1.2
    • [^123/131I] azetidinylamide a novel radiotracer for diagnosis and treatment of adrenocortical tumours -- from bench to bedside

      ea0037oc1.3
    • ¹¹C-metomidate PET-CT in primary aldosteronism: five possible indications for a non-invasive alternative to adrenal vein sampling

      ea0037oc1.4
    • Norepinephrine transporter as a predictive marker of response to PI3K/mTOR inhibition in phaeochromocytoma

      ea0037oc1.5
  • Reproduction
  • • Decanoic acid inhibits androgen production in vitro and in vivo by regulating HSD3B2: a promising drug candidate for the management of hyperandrogenism in polycystic ovary syndrome

      ea0037oc2.1
    • Lipid accumulation product as a surrogate marker of metabolic syndrome in different phenotypes of polycystic ovary syndrome

      ea0037oc2.2
    • Restoration of fertility in hypogonadal LH receptor null background male mice by a constitutive active mutant FSH receptor

      ea0037oc2.3
    • Low free testosterone is associated with hypogonadal symptoms in men with normal total testosterone levels: results from the European Male Ageing Study

      ea0037oc2.4
    • Bisphenol A-induced epithelial-mesenchymal transition was reversed with a phytoestrogen, genistein via oestrogen receptor and downregulation of transforming growth factor-beta signalling pathway

      ea0037oc2.5
  • Calcium, vitamin D and bone
  • • Effect of GNAS transcript manipulation on human mesenchymal stem cells differentiation towards osteocyte cell lineage: insight into the pathophysiology of ectopic ossification in GNAS-related disorders

      ea0037oc3.1
    • The association of sclerostin serum levels with sclerostin expression in bone

      ea0037oc3.2
    • Klotho expression in long bones is critical for FGF23 production during renal failure

      ea0037oc3.3
    • Cardiovascular risk factors in patients with medically observed and operated primary hyperparathyroidism

      ea0037oc3.4
    • Three-year safety and efficacy data for recombinant human parathyroid hormone, rhPTH(1-84), in the treatment of adults with hypoparathyroidism: the RACE study

      ea0037oc3.5
  • Diabetes
  • • Novel glucagon receptor antagonist peptides improve glycaemic control and partially protect against streptozotocin induced diabetes in mice

      ea0037oc4.1
    • Complement factor 5 deficiency leads to defective insulin receptor processing and severe systemic insulin resistance

      ea0037oc4.2
    • Chronic, long-term administration of Vardenafil improves endothelial function and corrects hypogonadism in patients with type 2 diabetes mellitus. A longitudinal, prospective, randomized, placebo-controlled, double blind, clinical trial

      ea0037oc4.3
    • Islet stellate cell isolated from Goto-Kakizaki rats affects β-cell function

      ea0037oc4.4
    • Efficacy of mesenchymal stem cells transplantation on glycaemic profile in streptozotocin induced diabetic Wistar rat

      ea0037oc4.5
  • Steroids, developmental and paediatric endocrinology
  • • Maternal microbiota regulate glucocorticoids levels and placental development in mice

      ea0037oc5.1
    • Vitamin D decreases in vitro glucocorticoid sensitivity via down regulation of glucocorticoid receptor expression

      ea0037oc5.2
    • Activators of AMP-activated protein kinase regulate adipocyte aldosterone secretion and mineralocorticoid receptor signalling

      ea0037oc5.3
    • Adipose tissue-specific androgen generation fuels an adverse metabolic phenotype in patients with polycystic ovary syndrome

      ea0037oc5.4
    • Pituitary hormone secretion profiles in IGSF1 deficiency syndrome

      ea0037oc5.5
  • Thyroid
  • • 3,5-T2 might play a crucial role in the rodent heart

      ea0037oc6.1
    • Biological activity of novel thyroid hormone analogues: role of Na+ taurocholate cotransporting polypeptide in liver selectivity

      ea0037oc6.2
    • Different TSH suppressive effects of liothyronine combination according to Thr92Ala type 2 deiodinase polymorphism

      ea0037oc6.3
    • The usefulness of determining the presence of BRAF (V600E) mutation in fine needle aspiration cytology of thyroid nodules cells

      ea0037oc6.4
    • Search for new candidate genes in RET mutation-negative families with hereditary medullary thyroid carcinoma using next generation sequencing

      ea0037oc6.5
  • Neuroendocrinology and pituitary-basic
  • • Genetic screening of regulatory regions of pituitary transcription factors among patients with idiopathic pituitary hormone deficiencies

      ea0037oc7.1
    • KLF4 in hypothalamus regulates leptin homeostatic effects through AgRP

      ea0037oc7.2
    • Maternal distress associates with placental genes regulating foetal glucocorticoid exposure and IGF2: role of obesity and sex

      ea0037oc7.3
    • Gonadotropin-inhibitory hormone signalling displays sexually dimorphic roles in the control of energy homeostasis: studies in the NPFF1 receptor null mouse

      ea0037oc7.4
    • Not so giants: mice lacking both somatostatin and cortistatin have high GH levels, but show no changes in growth rate or IGF-I levels

      ea0037oc7.5
  • Endocrine tumours
  • • A role for vault particles as a marker for therapeutic effects against endocrine tumours

      ea0037oc8.1
    • Role of microenvironment on neuroblastoma SK-N-AS SDHB silenced cell metabolism and function

      ea0037oc8.2
    • miR-372 is aberrantly expressed in most parathyroid tumours and might contribute to parathyroid tumourigenesis by inhibiting CDKN1A/p21 and LATS2

      ea0037oc8.3
    • The effects of peptides with oestrogen-like activity on cell proliferation and on energy metabolism in human derived tumour cell lines

      ea0037oc8.4
    • Oestrogen receptor α promotes prostate cancer progression through dual actions in both epithelia and stroma

      ea0037oc8.5
  • Adrenal 2
  • • Effects of dexamethasone and adrenocorticotropin on circulating microRNA expression in humans

      ea0037oc9.1
    • Alternative pathway synthesis dominates androgen production in patients with congenital adrenal hyperplasia and is decreased by Chronocort^® more than by conventional glucocorticoid therapy

      ea0037oc9.2
    • Modelling the salivary cortisone to serum cortisol inter-relationship to predict serum cortisol under physiological conditions and after hydrocortisone

      ea0037oc9.3
    • More than 2.5-fold increased risk for adrenal crises in patients with Addison's disease and the autoimmune polyglandular syndrome compared with secondary adrenal failure: German health insurance data 2010--2013

      ea0037oc9.4
    • The Notch ligand Jagged1 is up-regulated in adrenocortical carcinomas and is associated with a favourable clinical outcome

      ea0037oc9.5
  • Nuclear receptors and signalling
  • • Resistin negatively regulates neuronal adiponectin signalling through the down regulation of APPL1 and adiponectin receptors

      ea0037oc10.1
    • Odontella aurita-enriched high-fat diet prevents high-fat diet induced insulin resistance

      ea0037oc10.2
    • The thyroid hormones antagonize TGFβ responses suppressing fibrosis

      ea0037oc10.3
    • An autoregulatory loop of nuclear corepressor 1 expression controls hepatocarcinoma invasion, growth and metastasis

      ea0037oc10.4
    • A genome-wide shRNA screen to identify genes regulating ERα signalling and oestrogen-dependent proliferation in breast cancer cells

      ea0037oc10.5
  • Obesity
  • • Central resitin infusion impairs FGF21/FGFR1/β-Klotho hypothalamic expression and promotes peripheral FGF21 resistance: involvement of resistin/TLR4 signalling pathway

      ea0037oc11.1
    • Serum glypican-4 levels and its association with cardiovascular risk predictor in women with polycystic ovary syndrome and healthy controls -- pilot study

      ea0037oc11.2
    • microRNA profiling of H295R cells following stimulation of aldosterone production: a bioinformatic study

      ea0037oc11.3
    • Unacylated ghrelin and its analogue AZP-531 suppress ghrelin induced fat accumulation and feeding behaviours in high-fat diet fed male rats

      ea0037oc11.4
    • Preliminary analysis of the PRIMAVERA Study: reduxine safety monitoring in patients with alimentary obesity

      ea0037oc11.5
  • Pituitary – Clinical
  • • The Irish TSHoma study: a multicentre retrospective study

      ea0037oc12.1
    • The ubiquitin-specific protease 8 gene is frequently mutated in adenomas causing Cushing's disease

      ea0037oc12.2
    • The genetic causes of pituitary gigantism

      ea0037oc12.3
    • The changing faces of corticotroph-cell adenomas: the role of proconvertase 1/3

      ea0037oc12.4
    • The clinical characteristics of X-linked acro-gigantism syndrome

      ea0037oc12.5
• Guided Posters
• • Adrenal
  • • Low-dose ACTH testing does not predict treatment response to corticosteroids in community-acquired pneumonia

      ea0037gp.01.01
    • Defining and exploring the excessive healthcare burden of adrenal insufficiency

      ea0037gp.01.02
    • Effect of the switch from conventional glucocorticoids to 'dual release hydrocortisone' in adult patients with primary and secondary adrenal insufficiency: a 6-month multicentre study

      ea0037gp.01.03
    • Clinical and genetic findings of an Italian series of patients with ACTH resistance syndromes

      ea0037gp.01.04
    • Prevention of adrenal crisis in stress (The PACS Study): serum cortisol during elective surgery, acute trauma and sepsis in comparison to 'stress dose' hydrocortisone administration in adrenal insufficiency

      ea0037gp.01.05
    • Incidence of adrenal insufficiency and its relation to mortality in patients with septic shock

      ea0037gp.01.06
    • Mild cognitive deficits in patients on long-term, stable hydrocortisone replacement for primary adrenal insufficiency: a case-control study

      ea0037gp.01.07
    • Autoimmune polyendocrine syndrome in India: clinical aspects, AIRE mutations, and functional analysis

      ea0037gp.01.08
  • Adrenal (1)
  • • Steroid profiling by liquid chromatography-tandem mass spectrometry in patients with non-secreting adrenocortical adenomas and subclinical hypercortisolism

      ea0037gp.02.01
    • Urinary glucocorticoid metabolites and adrenal incidentalomas?

      ea0037gp.02.02
    • Differential expression of the PKA subunits in adrenocortical adenomas

      ea0037gp.02.03
    • Mortality in patients with incidentally discovered adrenal adenomas: the experience of San Luigi Hospital

      ea0037gp.02.04
    • Comparison between PET-CT and CT in the diagnosis of recurrence of adrenocortical carcinoma

      ea0037gp.02.05
    • DNA methylation of FKBP5 and its relationship with hippocampal volumes in Cushing's syndrome patients

      ea0037gp.02.06
    • Urinary free cortisone as a potential biomarker in diagnosing patients with mild Cushing's syndrome

      ea0037gp.02.07
    • ACTH-ectopic syndrome in four patients, caused by phaeochromocytoma

      ea0037gp.02.08
  • Adrenal (2)
  • • Pregnancy in women with non-classical congenital adrenal hyperplasia: time to conceive and outcome

      ea0037gp.03.01
    • Androgens and erythropoiesis in females: an insight from patients with congenital adrenal hyperplasia

      ea0037gp.03.02
    • Radiofrequency bipolar ablation therapy for primary aldosteronism patients: investigator-initiated exploratory clinical trial

      ea0037gp.03.03
    • Prolactinoma and primary aldosteronism: is there a causal link?

      ea0037gp.03.04
    • Short-term blood pressure response to mineralocorticoid-receptor blockade in aldosteronisms: primary hyperaldosteronism vs aldosterone-associated hypertension/low-renin hypertension

      ea0037gp.03.05
    • Applying a new decision threshold to an old test: does the measurement of plasma metanephrines in patients fasting and supine improve diagnostic sensitivity?

      ea0037gp.03.06
    • Comparison of urinary metanephrine concentrations after unilateral adrenalectomy for pheochromocytoma to healthy subjects

      ea0037gp.03.07
    • Obstructive sleep apnea presenting as pseudophaeochromocytoma

      ea0037gp.03.08
  • Steroids
  • • Dual 5[alpha]-reductase inhibition causes hepatic lipid accumulation in man

      ea0037gp.04.01
    • The modulation of corticosteroid metabolism by hydrocortisone therapy in patients with hypopituitarism increases tissue glucocorticoid exposure

      ea0037gp.04.02
    • Using a morning cortisol to predict adrenal reserve and guide management

      ea0037gp.04.03
    • Regulation of lipogenesis in human hepatocytes by androgens, glucocorticoids, and 5[alpha]-reductase

      ea0037gp.04.04
    • Glucocorticoid receptor and HSD11B1 gene polymorphisms influence the therapy and therapy-associated morbidities in patients with Addison's disease

      ea0037gp.04.05
    • Testosterone, androstenedione, cortisol, and cortisone levels in unstimulated, stimulated, and parotid saliva

      ea0037gp.04.06
    • Differential regulation of 11[beta]-hydroxysteroid dehydrogenase type 1 activity in patients with differing aetiologies of hypopituitarism

      ea0037gp.04.07
    • Circadian variation in serum cortisol during hydrocortisone replacement is not attributable to changes in cortisol-binding globulin

      ea0037gp.04.08
    • The influence of short-term and prolonged glucocorticosteroid therapy of immunoinflammatory diseases on carbohydrate metabolism

      ea0037gp.04.09
  • Developmental and paediatric endocrinology
  • • Regulation of murine skeletal muscle mass by testosterone and 17[beta]-oestradiol

      ea0037gp.05.01
    • The differential impact of PAPS synthase isoforms on DHEAS may be explained by an isoform-specific interaction of SULT2A1 with PAPSS2, but not PAPSS1

      ea0037gp.05.02
    • Determination of the topology of microsomal 17[beta]-hydroxysteroid dehydrogenase enzymes using redox-sensitive green fluorescence protein fusions

      ea0037gp.05.03
    • Pilot study on the effects of cross-sex hormone treatment in transsexual persons on metabolism by means of metabolomics profiling

      ea0037gp.05.04
    • Does the initiation of oestrogen therapy time affect final height and late metabolic outcomes in Turner syndrome?

      ea0037gp.05.05
    • Comparison of seven LC-MS/MS methods for the simultaneous measurement of testosterone, androstenedione, and DHEA in serum

      ea0037gp.05.06
    • Prediction of affective disorders in adult men on the basis of steroid profiling

      ea0037gp.05.07
    • A simple and rapid method for steroid profiling by two dimensional liquid chromatography-tandem mass spectrometry: toward routine application

      ea0037gp.05.08
    • Investigation of the effects of aldosterone on the cardiac cycle in the HL-1 mouse atrial cardiomyocyte cell line

      ea0037gp.05.09
    • Ghrelin and GHSR1 receptor in placentas of SGA, LGA, and AGA newborns

      ea0037gp.05.10
  • Reproduction: Female and PCOS
  • • Habitual physical activity is associated with lower prevalence of insulin resistance in women with polycystic ovary syndrome

      ea0037gp.06.01
    • Early diagnostics of insulin resistance in obese pregnant women

      ea0037gp.06.02
    • Characteristics of lipid profile in different phenotypes of polycystic ovary syndrome

      ea0037gp.06.03
    • Phenotypic characteristic of type 1 diabetic women with polycystic ovary syndrome

      ea0037gp.06.04
    • Cytokine expression in SAT and VAT from PCOS patients and control women; possible proinflammatory effect of testosterone depending on BMI - a preliminary report

      ea0037gp.06.05
    • Does finasteride, as well as metformin, improve insulin resistance in PCOS?

      ea0037gp.06.06
    • The effect of metformin and liraglutide on markers of subclinical atherosclerosis in women with polycystic ovary syndrome

      ea0037gp.06.07
    • Plasma brain derived neurotrophic factor is decreased in women with polycystic ovary syndrome and related to the markers of endothelial dysfunction

      ea0037gp.06.08
  • Reproduction: Female and other
  • • Preconceptional TSH and miscarriage in infertile women submitted to IVF

      ea0037gp.07.01
    • Kisspeptin increased during reproductive ageing and is regulated by sympathetic nerve system

      ea0037gp.07.02
    • The role of transvaginal ultrasonography in the evaluation of endometrial hyperplasia or cancer in pre- and perimenopausal women

      ea0037gp.07.03
    • Expression of melanocortin receptors in human endometrium

      ea0037gp.07.04
    • mRNA expressions of skin steroidogenic enzymes in women with idiopathic hirsutism

      ea0037gp.07.05
    • Difficulties in the evaluation of hirsutism using the modified Ferriman-Gallwey scale

      ea0037gp.07.06
    • Incretin release in a different state of testosterone level among lean PCOS women - case control study

      ea0037gp.07.07
  • Reproduction: Male and endocrine disruptors
  • • Characteristics and predictors of primary hypogonadism in ageing men: longitudinal data from the European Male Ageing Study

      ea0037gp.08.01
    • Deregulation of Sertoli and Leydig cells function in patients with Klinefelter syndrome as evidenced by testis transcriptome analysis

      ea0037gp.08.02
    • Infertile men have frequently Leydig cell dysfunction: study on hypogonadism, vitamin D and bone mass in 5177 subjects

      ea0037gp.08.03
    • Triclosan-induced breast cancer growth was antagonised by kaempferol, a phytoestrogen, via regulating cell cycle, migration and apoptosis related genes in MCF-7 breast cancer cells

      ea0037gp.08.04
    • Involvement of oestrogen receptor-[alpha] in [gamma]-cyhalothrin and cypermethrin-induced cancer growth in BG-1 ovarian cancer cells expressing oestrogen receptor

      ea0037gp.08.05
    • Bisphenol A affects amelogenesis by modulating enamel key genes expression

      ea0037gp.08.06
    • Cord blood insulin-like peptide 3 is reduced in idiopathic cryptorchidism and inversely related to free bisphenol A: a marker and/or an actor of foetal exposure to endocrine disruptors?

      ea0037gp.08.07
    • Evidence of stimulation of pubertal development and suppression of growth rate in boys smoking marijuana in cigarettes

      ea0037gp.08.08
  • Nuclear receptors and signalling
  • • Comparison of mRNA expression pattern of retinoid and retinoid X nuclear receptor subtypes in thyroid carcinomas, breast cancer and renal carcinomas

      ea0037gp.09.01
    • Proliferative vs apoptotic signals in granulosa cells: [beta]-arrestins as switch between life and death in vitro

      ea0037gp.09.02
    • Agonist-selective phosphorylation of the human sst3 somatostatin receptor determined by phosphosite-specific antibodies

      ea0037gp.09.03
    • Characterisation of insulin and [beta]2-adrenergic receptor heteromers: experimental and bioinformatics approach

      ea0037gp.09.04
    • Neuroprotective effects of 17[beta]-oestradiol: a therapeutic potential drug for Alzheimer's disease

      ea0037gp.09.05
    • Effects of estrogens on endothelial-derived factors implicated in the atheromatic plaque vulnerability-clarification of the molecular mechanisms

      ea0037gp.09.06
    • Androgen modulates expression of energy-related genes in brown adipocytes

      ea0037gp.09.07
    • Study of a possible interaction between reactive oxygen species and the mTORC1 pathway in the regulation of energy balance

      ea0037gp.09.08
  • Calcium, Vitamin D and Bone
  • • Roles of membrane oestrogen receptor alpha in bone sparing effects of oestrogens

      ea0037gp.10.01
    • Comparison of two methods in assessment of fracture risk of postmenopausal women with osteopenia

      ea0037gp.10.02
    • Local administration of non-diabetic MSCs to diabetic femoral fractures enhances callus remodelling and deposition of reparative bone

      ea0037gp.10.03
    • Osteoporosis and osteopenia in patients after kidney and pancreas transplantation

      ea0037gp.10.04
    • Effect of 1-year cross-sex hormonal treatment on bone mineral density of the lumbar spine in transgender patients

      ea0037gp.10.05
    • The (CAG)n repeat polymorphism of the androgen receptor gene is associated with bone mineral density in menopausal women

      ea0037gp.10.06
    • Abstract unavailable

      ea0037gp.10.07
    • Role of vitamin D levels and vitamin D supplementation on bone mineral density in Klinefelter syndrome

      ea0037gp.10.08
    • Serum cystatin C levels were correlated with cardiometabolic features and cardiovascular diseases in patients with primary hyperparathyroidism

      ea0037gp.10.09
    • Phenotype-genotype correlation in a series of 131 patients studied for calcium-sensing receptor gene

      ea0037gp.10.10
  • Calcium, Vitamin D and Bone (1)
  • • Abstract unavailable

      ea0037gp.11.01
    • Hypocalcaemia development in patients operated for primary hyperparathyroidism: can it be predicted preoperatively?

      ea0037gp.11.02
    • The evaluation of central corneal and retinal thickness and intraocular pressure in patients with primary hyperparathyroidism

      ea0037gp.11.03
    • Secondary hyperparathyroidism in HIV patients and its relation to cardiovascular risk factors

      ea0037gp.11.04
    • Determination of reference values for serum total 1,25-dihydroxyvitamin D3 using an extensively validated 2D ID-UPLC-MS/MS method

      ea0037gp.11.05
    • Relationship between serum 25-hydroxivitamin D3 and adipose tissue vitamin D receptor gene expression with obesity and type 2 diabetes

      ea0037gp.11.06
    • Tainted vitamin D responses under methyl donor deficiency of the pre-osteoblast cells are caused by a decreased VDR expression and a disruption of PGC-1a: VDR co-regulators complex

      ea0037gp.11.07
    • Associations of visceral and hepatic fat with serum 25-hydroxyvitamin D concentrations

      ea0037gp.11.08
    • Physical performance in women with vitamin D deficiency

      ea0037gp.11.09
  • Diabetes and obesity – Translational diabetes
  • • Comparison of umbilical cord ghrelin concentrations in full-term pregnant women with or without gestational diabetes

      ea0037gp.12.01
    • EATM regulates the NADPH-oxidases of erythrocyte membranes and serum of patients with types 1 and 2 diabetes ex vivo

      ea0037gp.12.02
    • Can physical activity modify the impact of the genes on the incidence of type 2 diabetes mellitus?

      ea0037gp.12.03
    • Efficacy of autologous bone marrow derived mesenchymal stem cell transplantation in T2DM: a randomised placebo-controlled study

      ea0037gp.12.04
    • Telomere biology and vascular ageing in patients with T2DM

      ea0037gp.12.05
    • Increased levels of Dickkopf-1 may indicate lower osteoblast signaling, predisposing to lower bone mineral density in children and adolescents with type 1 diabetes mellitus

      ea0037gp.12.06
    • GLP-1 (Active 7-36) secretory response after test meal in obese patients before and 5; 90 and 180 days after bariatric gastric bypass surgery

      ea0037gp.12.07
  • Diabetes and obesity – Translational cardiovascular and obesity
  • • Investigating chemerin/CMKLR1 signalling as a novel link between obesity and inflammatory bowel disease

      ea0037gp.13.01
    • Screening for genetic and structural variation in the NPY2R gene in obese children and adolescents

      ea0037gp.13.02
    • Effects of dietary glycaemic properties on markers of inflammation, insulin resistance and body composition in postmenopausal women

      ea0037gp.13.03
    • Metabolic and gonadotropic impact of sequential obesogenic insults in the female: influence of the loss of ovarian secretion

      ea0037gp.13.04
    • The effects of cross-sex hormone therapy on body weight and fat percentage in transgender individuals

      ea0037gp.13.05
    • Effects of testosterone replacement therapy on lean body mass, total fat mass, and insulin sensitivity in aging men with type 2 diabetes - a randomised, double-blinded, placebo-controlled trial

      ea0037gp.13.06
    • Three out of four adult male patients with type 2 diabetes mellitus and symptomatic moderate to severe erectile dysfunction have hypogonadism

      ea0037gp.13.07
    • Eating disorders are frequent among type 2 diabetic patients and are associated with worse metabolic and psychological outcomes: results from a cross sectional study in primary and secondary care settings

      ea0037gp.13.08
  • Diabetes and obesity – Clinical diabetes
  • • What components drive the metabolic syndrome? Results from the population-based LifeLines Cohort Study

      ea0037gp.14.01
    • Changes of metabolic syndrome and its components in early adolescents through a 9.9 year community-based lifestyle intervention: Tehran Lipid and Glucose Study

      ea0037gp.14.02
    • Clinical and biological determinants of metabolically healthy obese status

      ea0037gp.14.03
    • Parental obesity in association with offspring cognitive and psychomotor development at 4 years of age: the mother child 'Rhea' cohort in Crete, Greece

      ea0037gp.14.04
    • The effect of Roux-en-Y gastric bypass, sleeve gastrectomy and adjustable gastric banding on renal function and remission of metabolic disease: a five-year longitudinal study

      ea0037gp.14.05
    • Higher HOMA levels and failed decrease in body fat can be considered unfavourable predictors of restoring euglycaemia in diabetic cirrhotic patients undergoing liver transplantation

      ea0037gp.14.06
    • Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

      ea0037gp.14.07
    • Factors associated with islet yield and insulin independence after total pancreatectomy and islet cell autotransplantation in patients with chronic pancreatitis utilising off-site islet isolation: Cleveland Clinic experience

      ea0037gp.14.08
  • Diabetes and obesity – basic
  • • Topical application of CD362+ human mesenchymal stem cells (cyndacel-M) seeded in Excellagen scaffold augments wound healing and increases angiogenesis in a diabetic rabbit ulcer model

      ea0037gp.15.01
    • Sex hormone-binding globulin protects against non-alcoholic fatty liver disease

      ea0037gp.15.02
    • Cardiomyopathy in the male obese diabetic db/db mice is alleviated by oxytocin treatment

      ea0037gp.15.03
    • Novel human resistin antagonist (monomeric C6A mutant) reduced body weight gain and restored insulin responsiveness in mice fed high fat diet

      ea0037gp.15.04
    • Stable analogues of the dual agonist dogfish glucagon show better therapeutic potential than exendin-4 in diet induced obese diabetic mice

      ea0037gp.15.05
    • Activation of GPR120 by lipid agonists modulates glucagon secretion in pancreatic islets and improves glucose tolerance in mice

      ea0037gp.15.06
    • Nephroprotective properties of metformin and vildagliptin: experimental facts in type 2 diabetes

      ea0037gp.15.07
  • Diabetes and obesity–Clinical obesity and cardiovascular
  • • Suppression of plasma free fatty acid concentrations similarly reduces myocardial lipid content and left ventricular systolic function in type 2 diabetic patients and healthy controls

      ea0037gp.16.01
    • The effect of omega-3 polyunsaturated fatty acids on the arterial stiffness parameters in patients with diabetes mellitus type 2 and cardiovascular autonomic neuropathy

      ea0037gp.16.02
    • The dipeptidyl peptidase-IV inhibitor (gemigliptin) inhibits the expression of vascular adhesion molecules and inflammatory cytokines in HUVECs via Akt- and AMPK-dependent mechanisms

      ea0037gp.16.03
    • Nocturnal blood pressure cut off points related to the development of microvascular complications and arterial hypertension in patients with type 1 diabetes

      ea0037gp.16.04
    • Evaluation of cardiovascular risk factors in long-term survivors of brain tumours who received cranial irradiation

      ea0037gp.16.05
    • Cardiovascular complications in type 1 diabetic patients

      ea0037gp.16.06
    • Lipocalin-2 regulates cardiomyocyte autophagy to control apoptosis and insulin sensitivity: importance in heart failure

      ea0037gp.16.07
    • Vascular and cardiac function in young adults with classical congenital adrenal hyperplasia

      ea0037gp.16.08
  • Pituitary–Neuroendocrinology and central salt regulation
  • • Retinoic acid increases glucocorticoid receptor phosphorylation via cyclin-dependent kinase 5

      ea0037gp.17.01
    • Glp-1 regulates the reproductive function and synchronizes the onset of the puberty in female rats

      ea0037gp.17.02
    • Insulin-induced hypoglycaemia decreases IGF1 bioactivity in humans: a missing link to increased mortality in diabetic patients?

      ea0037gp.17.03
    • Copeptin reflects thermal strain during exercise in a hot environment

      ea0037gp.17.04
    • Hypernatremia and copeptin levels in the elderly hospitalised patient

      ea0037gp.17.05
    • Predictors of response to fluid restriction in hyponatremic patients due to the syndrome of inappropriate antidiuresis

      ea0037gp.17.06
    • Heterogenous patterns of recovery from adipsic diabetes insipidus in adult patients

      ea0037gp.17.07
    • A study of hyponatraemia in acute medical admissions

      ea0037gp.17.08
    • The dopastatin BIM-23A760 distinctly influences key functional endpoints in different types of pituitary adenomas and normal pituitaries: role of somatostatin and dopamine receptor profile

      ea0037gp.17.09
  • Pituitary–Basic and IGF-1
  • • Chronic stress decreases circulating endocannabinoid 2-arachidonoylglycerol in healthy human subjects

      ea0037gp.18.01
    • Neuroactive steroids as predictive markers for Alzheimer's disease

      ea0037gp.18.02
    • Regulation of sexually dimorphic growth of murine skeletal muscle by Stat5a and Stat5b

      ea0037gp.18.03
    • A small hypothalamic volume correlates with impaired cognitive outcome in childhood onset craniopharyngioma on long-term follow up

      ea0037gp.18.04
    • Presence and functional actions of In1-ghrelin splicing variant reveals a potentially relevant pathophysiological role in human pituitary adenomas

      ea0037gp.18.05
    • Comparison of high-throughput platforms in evaluation of whole genome miRNA expression profiles in pituitary tissues

      ea0037gp.18.06
    • The hypothyroidism alters circadian clock expression in anterior pituitary gland

      ea0037gp.18.07
    • Role of miR-375 in oncogenesis of pituitary adenomas

      ea0037gp.18.08
    • Molecular classification of pituitary adenomas

      ea0037gp.18.09
  • Pituitary–Acromegaly
  • • Coagulation parameters and platelet function analysis in patients with acromegaly

      ea0037gp.19.01
    • Assessment of bone quality, measured by trabecular bone score, in acromegaly

      ea0037gp.19.02
    • Perceived quality of life in acromegaly: results from a tertiary UK centre

      ea0037gp.19.03
    • Molecular and pathological determinants of somatostatin analogue resistance: somatotropinomas in AIP mutated and X-LAG syndrome patients

      ea0037gp.19.04
    • Clinical and biochemical outcomes during pregnancy in patients with acromegaly

      ea0037gp.19.05
    • Criteria for disease control in acromegaly under SSA treatment: mean GH profile or GH random?

      ea0037gp.19.06
    • Patient experience of living with acromegaly in the UK

      ea0037gp.19.07
    • Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly

      ea0037gp.19.08
    • Management of pasireotide-induced hyperglycaemia with proactive monitoring and early intervention: key learnings from the phase III, 24-week PAOLA study

      ea0037gp.19.09
    • A phase 2 study of antisense oligonucleotide therapy directed at the GH receptor demonstrates lowering of serum IGF1 in patients with acromegaly.

      ea0037gp.19.10
  • Pituitary – Hypopituitarism
  • • Reduced mortality due to malignant neoplasms in patients receiving long-term GH replacement therapy - a Swedish study based on more than 4000 patient-years

      ea0037gp.20.01
    • Association of serum IGF1 concentration with cardiovascular function in adults with GH deficiency with different GH treatment regimes: a randomised clinical trial

      ea0037gp.20.02
    • Timing is everything? Postpartum pituitary dysfunction - variability of clinical and radiological presentation

      ea0037gp.20.03
    • Irradiation-induced hypopituitarism in adult brain tumour survivors: single-centre longitudinal data

      ea0037gp.20.04
    • Long-term follow-up of 520 patients with non-functioning pituitary adenomas from two large tertiary referral centres: a UK-Republic of Ireland collaborative study

      ea0037gp.20.05
    • Somatic complaints, pain and health related quality of life in patients treated for secondary adrenal insufficiency - results from a randomised controlled trial

      ea0037gp.20.06
    • Outcome and prognosis of typical and atypical pituitary adenomas in a monocentric experience

      ea0037gp.20.07
    • 'Pseudo-resistance' in macroprolactinomas treated with dopamine agonists; recognising delayed radiological response and a role for 11C-methionine PET-CT in guiding management

      ea0037gp.20.08
    • Thyrotropinoma: diagnosis and management of a rare but increasingly recognised pituitary tumour - novel insights from a large prospective UK study

      ea0037gp.20.09
  • Pituitary – Diagnosis of Cushing's disease
  • • A reappraisal of second line tests in the differential diagnosis of ACTH-dependent Cushing's syndrome: the role of three dynamic tests

      ea0037gp.21.01
    • Bilateral inferior petrosal sinus sampling reliably differentiates pituitary from ectopic Cushing's, but frequently fails to predict pituitary tumour location, especially when lateralizing to the right

      ea0037gp.21.02
    • Altered neural processing during emotional faces in remitted Cushing's disease

      ea0037gp.21.03
    • Exaggerated and additive ACTH responses following the combined ghrelin+CRH test in patients with Cushing's disease

      ea0037gp.21.04
    • Mental fatigue and executive dysfunction in patients with Cushing's syndrome in remission

      ea0037gp.21.05
    • Prolactine and urinary free cortisol measurement improve inferior petrosal sinus sampling results in ACTH dependent Cushing's Syndrome

      ea0037gp.21.06
  • Pituitary–Therapy of Cushing's disease
  • • Phase III, multicentre, double-blind, randomised withdrawal study of osilodrostat (LCI699) in patients with Cushing's disease: a study design

      ea0037gp.22.01
    • Surgical outcome and factors associated with Cushing's disease recurrence in 101 consecutive patients operated on by a single pituitary neurosurgeon: the Cleveland Clinic experience

      ea0037gp.22.02
    • Impact of preoperative magnetic resonance in surgical care of patients with Cushing's disease

      ea0037gp.22.03
    • Long-term (5 years) treatment of Cushing's disease with pasireotide

      ea0037gp.22.04
    • Effects of osilodrostat (LCI699) on cytochrome P450 enzymes in healthy volunteers indicates a low drug-drug interaction potential

      ea0037gp.22.05
    • A specific nursing educational programme in patients with Cushing's syndrome

      ea0037gp.22.06
    • Neurosurgery outcome in patients with Cushing's disease with and without visualised pituitary adenoma on MRI, who underwent inferior petrosal sinus sampling

      ea0037gp.22.07
  • Thyroid – diagnosis
  • • Evaluation of strain elastography for differentiation of thyroid nodules: results of a prospective multicentre study

      ea0037gp.23.01
    • Accuracy of sentinel lymph node biopsy in papillary thyroid carcinoma in decision for selective lateral neck dissection

      ea0037gp.23.02
    • Incremental value of serial preablative thyroglobulin measurements in identifying distant metastatic differentiated thyroid cancer

      ea0037gp.23.03
    • Impact of antithrombotic and/or anticoagulant treatment in cytological results of thyroid fine-needle biopsy

      ea0037gp.23.04
    • Comparison of cytopathology vs thyroglobulin measurement in fine-needle aspiration biopsy in patients with differentiated thyroid cancer

      ea0037gp.23.05
    • FDG-avidity of thyroid cancer does not predict clinical aggressiveness in PET incidentaloma

      ea0037gp.23.06
    • Immunohistochemical tool for the diagnosis of benign and malignant follicular tumours

      ea0037gp.23.07
    • Clinical characteristics in sporadic and familial medullary thyroid carcinomas: worse outcome in sporadic cases even when disease stage at diagnosis is similar

      ea0037gp.23.08
    • Low/undetectable pre-ablation thyroglobulin in well-differentiated thyroid cancer patients with positive post-ablative 131I whole body scans: causes and consequences

      ea0037gp.23.09
  • Thyroid–genetics
  • • Prox1 transcription factor is differentially expressed in thyroid cancer and contributes to the regulation of invasion and migration of thyroid cancer cells

      ea0037gp.24.01
    • In papillary thyroid cancer TERT promoter mutations have a worst impact on outcome than BRAF mutations

      ea0037gp.24.02
    • Evaluation of genetic background of sporadic medullary thyroid carcinomas

      ea0037gp.24.03
    • Lymph node involvement using one-step nucleic acid amplification according to BRAF gene mutation status in patients with papillary thyroid carcinoma submitted to lymph node dissection

      ea0037gp.24.04
    • Telomerase reverse transcriptase promoter mutation analysis on thyroid core needle biopsy

      ea0037gp.24.05
    • Gene expression profiling in differentiated thyroid carcinoma

      ea0037gp.24.06
    • Combination of serum miRNA-190 and -95 is a powerful non-invasive tool in the differential diagnosis of thyroid nodules: preliminary data of a prospective series

      ea0037gp.24.07
    • Identification of a LIN28B/miR-30a axis controlling thyroid cell invasion and proliferation

      ea0037gp.24.08
  • Thyroid – nodule
  • • Long-term results of US-guided high-intensity focused ultrasound treatment of benign thyroid nodules

      ea0037gp.25.01
    • Thyroid hormones influence the expression of TNF-related apoptosis-inducing ligand

      ea0037gp.25.02
    • Malignancy rate in thyroid nodules with AUS/FLUS cytology in a Cancer Center (Bethesda System for Reporting Thyroid Cytopathology 2009)

      ea0037gp.25.03
    • Evaluation of benign thyroid nodules in a 10-year follow-up

      ea0037gp.25.04
    • Sox9 is expressed in thyroid follicular cells and regulates the expression of thyroid differentiation genes

      ea0037gp.25.05
    • Clinical outcome of thyroid nodules characterised as atypia of undetermined significance or follicular lesion of undetermined significance (The Bethesda System for Reporting Thyroid Cytopathology) after fine-needle aspiration

      ea0037gp.25.06
    • Malignancy risk stratification of thyroid nodules by TIRADS; correlation with cytological results

      ea0037gp.25.07
  • Thyroid – hypothyroidism
  • • Quality of life in primary hypothyroidism after long-term levothyroxine replacement

      ea0037gp.26.01
    • High serum IgG4 concentrations in patients with Hashimoto's thyroiditis

      ea0037gp.26.02
    • Adverse metabolic correlations relate to free T3 levels in subclinical hypothyroidism; common FOXE1 polymorphisms associate with blood pressure

      ea0037gp.26.03
    • Nkx2.5 gene mutations are not associated with congenital heart defects in children with thyroid dysgenesis

      ea0037gp.26.04
    • Oral liquid thyroxine assumed at breakfast: preliminary results of the TICO study

      ea0037gp.26.05
    • Analysis of hypothyroidism in patients admitted to internal medicine wards in Spain 2005-2012

      ea0037gp.26.06
    • Cardiovascular risk factors in autoimmune thyroiditis and subclinical hypothyroidism

      ea0037gp.26.07
    • Prevalence and clinical associations of calcium-sensing receptor and NALP5 autoantibodies in patients with autoimmune polyendocrine syndrome type 1

      ea0037gp.26.08
    • No effect of Thr92Ala DIO2 polymorphisms on thyroid parameters, health-related quality of life, and cognitive functioning

      ea0037gp.26.09
    • HLA-DR in Hashimoto's thyroiditis

      ea0037gp.26.10
  • Thyroid – hyperthyroidism and treatment
  • • The effect of TSH suppression therapy on the cortical bone geometry in the patients with differentiated thyroid cancer

      ea0037gp.27.01
    • MIVAT vs traditional thyroidectomy: a 5-year follow up in 284 cases

      ea0037gp.27.02
    • Clinical and biochemical factors affecting prognosis of disease persistence in micro papillary thyroid carcinomas

      ea0037gp.27.03
    • TIM16 inhibition enhances sensitivity to paclitaxel and decreases calcitonin secretion by reducing mitochondrial membrane potential in a human medullary thyroid carcinoma cell line

      ea0037gp.27.04
    • Effect of a very low dose of rituximab on active moderate-severe Graves' orbitopathy: an interim report

      ea0037gp.27.05
    • hCG levels are essential for the correct interpretation of gestational TSH levels: the clinical risk assessment of premature delivery

      ea0037gp.27.06
    • Plasmapheresis in thyroid storm caused by exogenous thyroid hormone intake: a case series

      ea0037gp.27.07
    • There is a detectable immune activity in the orbits of all patients diagnosed with Graves' disease regardless of later development of Graves' orbitopathy

      ea0037gp.27.08
  • Endocrine tumours and neoplasia – NETS
  • • Clinicopathologic features, treatments, and survival of patients with ectopic Cushing's syndrome from neuroendocrine tumours: data from an Italian multicentre study

      ea0037gp.28.01
    • Localisation of insulinoma: comparison of glucagon-like peptide 1 receptor SPECT/CT, PET/CT, and MRI: preliminary results of a prospective clinical study

      ea0037gp.28.02
    • Could 99mTc labelled glucagon-like peptide 1 analogue scintigraphy be an answer for patients with persistent hypoglycaemia?

      ea0037gp.28.03
    • Receptor tyrosine kinase expression and their role in the response to target therapy in bronchopulmonary NET

      ea0037gp.28.04
    • Filamin-A is involved in stabilisation, signal transduction, and angiogenesis regulation mediated by somatostatin receptor 2 in pancreatic neuroendocrine tumors

      ea0037gp.28.05
    • Patient-reported time to diagnosis of neuroendocrine tumors (NETs) in Europe: results from the first global NET patient survey: a collaboration between the International Neuroendocrine Cancer Alliance (INCA) and Novartis

      ea0037gp.28.06
    • Complete remission of hepatic metastasis after total gastrectomy for a gastric carcinoid tumor type 1: a case report

      ea0037gp.28.07
    • General characteristics and evaluation of [beta]-cell function and insulin sensitivity in a large monocentric series of insulinomas

      ea0037gp.28.08
    • Association of angiopoietin/TIE2 plasma level and VEGF system with progression in gastroenteropancreatic neuroendocrine tumors

      ea0037gp.28.09
  • Endocrine tumours and neoplasia – Adrenal Tumour
  • • Mitotane inhibits sterol-o-acyltransferase leading to lipid-mediated endoplasmic reticulum stress and apoptosis of adrenocortical carcinoma cells

      ea0037gp.29.01
    • Investigation of a novel liposomal chemotherapy protocol in three preclinical models for adrenocortical carcinoma in vivo

      ea0037gp.29.02
    • Immunoexpressions of CYP11B2 and HSD3B2 in genetically characterised aldosterone producing adenomas

      ea0037gp.29.03
    • Synergistic action of 9-cis retinoic acid and mitotane in a H295R adrenocortical cancer xenograft model

      ea0037gp.29.04
    • EGFR as potential new molecular target in the medical treatment of adrenocortical cancer

      ea0037gp.29.05
    • The incidence of consecutive manifestations of VHL disease

      ea0037gp.29.06
    • Penetrance and optimal surveillance for SDHB mutation carriers

      ea0037gp.29.07
  • Endocrine tumours and neoplasia – General
  • • Temozolomide treatment for pituitary aggressive tumours and pituitary carcinomas: initial results and long-term follow-up of a cohort of 32 cases

      ea0037gp.30.01
    • Clinicopathological significance of fractional allelic loss in prognosis of follicular cell-derived thyroid tumours

      ea0037gp.30.02
    • The role of androgen receptor in glucose transporters expression in prostate cancer cells

      ea0037gp.30.03
    • Re-introduction of type 1 iodothyronine deiodinase in renal cancer cells affects their migration and expression of adhesion-related genes

      ea0037gp.30.04
    • Targeted destruction of FSHR-positive cells by lytic peptide Phor21 conjugated with FSH[beta] subunit in vitro

      ea0037gp.30.05
    • The Wnt/[beta]-catenin pathway regulates the expression of early embryonic stem cell genes in human parathyroid tumours

      ea0037gp.30.06
    • Steroid metabolome analysis reveals that prostate cancer has potent 5[alpha]-reductase, 3[alpha]- and 17[beta]-hydroxysteroid dehydrogenase activities, but lacks 17-hydroxylase/17,20-lyase

      ea0037gp.30.07
• Eposter Presentations
• • Adrenal cortex
  • • Evaluation of cases by short synacthen test (dose: 250 [mu]g i.v.) suspected as secondary adrenal insufficiency of prolonged steroid abuse

      ea0037ep1
    • Management of urgent surgical intervention due to coexistence of phaeochromocytoma and hydrocephalus in a patient presenting with Von Hippel Lindau syndrome

      ea0037ep2
    • A case of polyglandular autoimmune syndrome type 1 with hypercalcaemia and hypotension

      ea0037ep3
    • The value of high effective liquid chromatography in the diagnosis of primary aldosteronism

      ea0037ep4
    • Influence of glucocorticoids on markers of inflammation in community-acquired pneumonia

      ea0037ep5
    • Clinical and pathological characteristics of hypertensive and normotensive adrenal phaeochromocytomas

      ea0037ep6
    • New onset sarcoidosis after remission of Cushing[apos]s syndrome

      ea0037ep7
    • Extra-adrenal myelolipomas in association with cortisol hypersecretion

      ea0037ep8
    • Salivary cortisol after overnight dexamethasone suppression test in different patient groups

      ea0037ep9
    • Overview of phaeochromocytomas at Vilnius University Hospital Santariskiu clinics (VUHSC): 5 year results

      ea0037ep10
    • Aldosterone- and cortisol-co-secreting adrenal adenoma in an adolescent girl: a case report

      ea0037ep11
    • Comparison of a RIA assay and a CLIA assay for aldosterone determination

      ea0037ep12
    • Does IGF-1 have a role in ethiopathogenesis of adrenal incidentaloma?

      ea0037ep13
    • Effects of megestrol acetate on adrenal function and survival in cancer patients

      ea0037ep14
    • The effect of retinoic acid on human adrenal corticosteroid secretion in vitro

      ea0037ep15
    • Adrenal malignant melanoma masquerading as a phaeochromocytoma

      ea0037ep16
    • Cushing[apos]s disease: experience in a third level hospital from Zaragoza (Spain)

      ea0037ep17
    • Subclinical Cushing[apos]s syndrome and clinical implications in bilateral compared to unilateral adrenal incidentalomas: a meta-analysis

      ea0037ep18
    • Association of psoriasis with Cushing[apos]s syndrome

      ea0037ep19
    • Should Cushing syndrome be only evaluated by endocrinologists and neurosurgeons?

      ea0037ep20
    • Necessity of thrombophylaxis in Cushing[apos]s syndrome

      ea0037ep21
    • Short Synacthen testing: are we referring appropriately and over diagnosing adrenal insufficiency?

      ea0037ep22
    • Primary hyperaldosteronism: predictors of response to therapy in Singapore

      ea0037ep23
    • Reduced salivary cortisone, but similar cortisol day curves in Addison[apos]s disease in patients on hydrocortisone replacement

      ea0037ep24
    • Problems in ACTH-ectopic syndrome diagnostics in clinical practice

      ea0037ep25
    • Primary adrenal lymphoma: case report

      ea0037ep26
    • Cushing[apos]s syndrome and diabetes

      ea0037ep27
    • Cushing[apos]s syndrome and dyslipidaemia

      ea0037ep28
    • Cushing[apos]s syndrome and hypertension

      ea0037ep29
    • Asymmetric dimethylarginine level and markers of atherosclerosis in Cushing[apos]s syndrome

      ea0037ep30
    • A case of aldosterone-secreting giant adrenal carcinoma: a case report

      ea0037ep31
    • The incidence and characteristics of adrenal insufficiency among patients with suspicious symptoms in general hospital in Korea

      ea0037ep32
    • A case of Addison[apos]s disease: high clinical suspicion should guide diagnosis and caution should be used when reviewing initial laboratory investigations

      ea0037ep33
    • Selective adrenal venous sampling is not always useful in primary aldosteronism

      ea0037ep34
    • The safety of steroid replacement and patient[apos]s knowledge

      ea0037ep35
    • Pituitary macroadenoma with adrenocortical hypersecretion as the initial presentation of compensated adrenocortical failure

      ea0037ep36
    • Pregnancy-induced Cushing[apos]s syndrome

      ea0037ep37
    • Cardiovascular system abnormalities in patients with Cushing[apos]s syndrome

      ea0037ep38
    • Clinical management of adrenal insufficiency shows significant heterogeneity: data from the EU-AIR study

      ea0037ep39
    • Postural orthostatic tachycardia syndrome unmasked by successful treatment of primary aldosteronism

      ea0037ep40
    • Effect of stress-dosed hydrocortisone on physical capacity in patients with Addison[apos]s disease

      ea0037ep41
    • Phenotypic characteristics of bilateral adrenal masses: about 34 cases

      ea0037ep42
    • Impact of congenital adrenal hyperplasia and glucocorticoid treatment on the final size and gonadal function

      ea0037ep43
    • Adrenal inclusions in congenital adrenal hyperplasia: clinical and progressive characteristics

      ea0037ep44
    • X-linked adrenal hypoplasia congenita with a novel DAX1 missense mutation

      ea0037ep45
    • Adrenal insufficiency during prednisolone treatment: need for cortisol replacement strategies in patients on long-term low-dose glucocorticoid treatment?

      ea0037ep46
    • A challenging case of paraneoplastic Cushing[apos]s syndrome

      ea0037ep47
    • The treatment with [lsquo]dual release[rsquo] hydrocortisone (DR-HC) in congenital adrenal hyperplasia: short-term (6 months) and long-term (12 months) follow-up after the switch from conventional glucocorticoids to DR-HC

      ea0037ep48
    • The effect of oxidative stress to cardiovascular risk profile among non-functional adrenal incidentaloma patients

      ea0037ep49
    • Malignant phaeochromocytoma: about seven observations

      ea0037ep50
    • Comparison of 17-OH progesterone response to various dose of tetracosactide

      ea0037ep51
    • Functional oncocytic adrenocortical tumour: a case report

      ea0037ep52
    • Beneficial effects of replacement therapy with modified-release hydrocortisone in patients with adrenal insufficiency

      ea0037ep53
    • A phase 1, randomised, open-label, four-period crossover, single-dose study to evaluate the pharmacokinetics of hydrocortisone modified release tablets

      ea0037ep54
    • Rare case of ectopic ACTH secreting tumour causing cyclical Cushing[apos]s syndrome

      ea0037ep55
    • Review of clinical presentation of primary hyperaldosteronism and identify unique features in our cohort

      ea0037ep56
    • To identify usefulness of adrenal vein sampling in clinical management of primary hyperaldosteronism

      ea0037ep57
    • Diagnosis of Cushing[apos]s syndrome using scalp hair cortisol

      ea0037ep58
    • Role for 131I-6[beta]-iodomethyl-norcholesterol scintigraphy in subclinical Cushing[apos]s syndrome with bilateral adrenal lesions

      ea0037ep59
    • Diagnostic pitfalls of Cushing[apos]s syndrome without specific clinical signs among patients with obesity

      ea0037ep60
    • The utility of current guidelines in the assessment of adrenal incidentalomas

      ea0037ep61
    • Prospective evaluation of cardiovascular risk in subclinical Cushing[apos]s syndrome

      ea0037ep62
    • Salivary cortisol values among nurses at Pathology and Emergency Department

      ea0037ep63
    • Serum brain-derived neurotrophic factor in Cushing[apos]s syndrome patients

      ea0037ep64
    • Urinary metanephrine levels can be spurious in the diagnosis of patients with phaeochromocytoma: preliminary results from a single centre

      ea0037ep65
    • Clinical significance of contralateral adrenal suppression during adrenal vein sampling in primary aldosteronism

      ea0037ep66
    • Glucocorticoid receptor polymorphisms not affect the therapy efficiency in adult, Hungarian patients with 21-hydroxylase deficiency

      ea0037ep67
    • The antidiabetic drug metformin affects H295R cells proliferation

      ea0037ep68
    • Prevalence and natural history of adrenal incidentalomas: a prospective cohort study

      ea0037ep69
    • Prevalence of hypercortisolism in type 2 diabetes patients: a meta-analysis

      ea0037ep70
    • Fludrocortisone therapy in patients with primary adrenal insufficiency: relationships with different hydrocortisone doses

      ea0037ep71
    • Prevalence of Cushing[apos]s syndrome at overweight and obese patients

      ea0037ep72
    • The clinical course of patients with adrenal incidentaloma: is it time to reconsider the current recommendations?

      ea0037ep73
    • An audit of the investigation and follow up of adrenal incidentalomas

      ea0037ep74
    • Biochemical control and clinical improvement is induced by long-term pasireotide administration in the majority of patients with Cushing[apos]s disease persistent after pituitary surgery

      ea0037ep75
    • Ectopic thyroid tissue in the adrenal gland: report of a case

      ea0037ep76
    • Prevalence of neoplasms in patients with primary aldosteronism

      ea0037ep77
    • Outcomes of short synacthen test in a university teaching hospital: are baseline and time 30 min sufficient?

      ea0037ep78
    • Functional muscle capacity and daily physical activity deficits in patients with endogenous Cushing[apos]s syndrome

      ea0037ep79
    • Metabolic abnormalities in patients with nonfunctional adrenal incidentaloma: random or causal?

      ea0037ep80
    • Acute adrenal insufficiency as a first sign of metastatic pulmonary carcinoma

      ea0037ep81
    • Marked hypercholesterolaemia caused by mitotane adjuvant chemotherapy for adrenocortical carcinoma

      ea0037ep82
    • Fasting during Ramadan in patients with adrenal insufficiency

      ea0037ep83
    • Awareness of adrenal crisis prevention in long-term steroid users

      ea0037ep84
    • Subclinical Cushing[apos]s syndrome: report of 17 cases

      ea0037ep85
    • Challenges in a the management of adrenal Cushing[apos]s syndrome associated with bilateral adrenal tumours and uterine leiomyoma

      ea0037ep86
    • Spectrum of presentation and aetiology of adrenal haemorrhage: a case series

      ea0037ep87
    • A single-centre 10-years experience with pasireotide in Cushing[apos]s disease: patients characteristics and outcome

      ea0037ep88
    • Low DHEAS: a sensitive and specific screening test for the detection of subclinical hypercortisolism in adrenal incidentalomas

      ea0037ep89
    • Ultrasound importance in adrenal incidentalomas diagnostication and management

      ea0037ep90
    • RNALDO: the effects of blocker withdrawal on renin and angiotensin

      ea0037ep91
    • Long-term outcome from unilateral adrenalectomy in patients with primary aldosteronism

      ea0037ep92
    • Phaeochromocytoma-the Mater hospital experience over the past two decades

      ea0037ep93
    • Combined effects of sirolimus and mitotane in the inhibition of growth in human adrenocortical carcinoma cells

      ea0037ep94
  • Steroids, development and paediatric endocrinology
  • • Linear growth and endocrine function in patients with ataxia telangiectasia; a cohort of 13 patients in Qatar

      ea0037ep95
    • Abstract unavailable

      ea0037ep96
    • Unusual presentation of the apparent mineralocorticoid excess, triggered by mild Cushing[apos]s disease in an adult

      ea0037ep97
    • Evaluation of [beta]-oestradiol induced DNA damage in the leukocytes of young, elderly and Alzheimer[apos]s disease patients in the comet assay

      ea0037ep98
    • Serum alanine aminotransferase and [gamma]-glutamyltranspeptidase activities: new markers for polycystic ovary syndrome

      ea0037ep99
    • Achievement of therapy targets in children and adolescents with type 1 diabetes mellitus at the [lsquo]Diabetes School[rsquo]

      ea0037ep100
    • Interrelation between level of knowledge and type 1 diabetes mellitus compensation degree in children and adolescents

      ea0037ep101
    • Influence of ecologically adverse factors on physical and sexual development of children living in the Aral Sea area

      ea0037ep102
    • Leptin and kisspeptin evaluation in childhood obesity

      ea0037ep103
    • Kisspeptin hormone levels in girls and adolescent girls

      ea0037ep104
    • Clinical and endocrine features Hashimoto thyroiditis in children and adolescents

      ea0037ep105
    • Neonatal screening for hypothyroidism in Romania

      ea0037ep106
    • Paediatric hypothyroidism: effect of thyroxin replacement therapy on growth hormone secretion and linear growth velocity

      ea0037ep107
    • Evolution of the signs of true precocious puberty under suppressive treatment by LH RH analogues in girls

      ea0037ep108
    • DHEA and its metabolites - daily profile

      ea0037ep109
    • Aetiologies of thick stalks pituitaries: about 24 observations

      ea0037ep110
    • The beast behind the dwarf

      ea0037ep111
    • Final size of turner patients: about 40 patients

      ea0037ep112
    • Sarcopenia, more that dehydration, may be associate to underweight Portuguese centenarians

      ea0037ep113
    • Salt and puberty: self-regulated salt intake and the effect of salt on puberty

      ea0037ep114
    • Exploring the psychosocial impact of congenital adrenal hyperplasia on children and their parents

      ea0037ep115
    • Biochemical and molecular modelling analyses explain the functional loss of HSD17B3 mutant G133R in three Tunisian patients

      ea0037ep116
    • Search for DHEASism and DHEASoma

      ea0037ep117
    • Psychological problems in children with diabetes mellitus type 1

      ea0037ep118
    • Influence of food on daily profiles of steroids

      ea0037ep119
    • Six-month interim safety and efficacy of different dose levels of transCon hGH administered once weekly versus standard daily human growth hormone replacement therapy in pre-pubertal children with growth hormone deficiency (GHD)

      ea0037ep120
    • Analysis of androgen profile in teenage girls and young women with acne of various severity

      ea0037ep121
    • The NCEP ATP III criteria may overestimate the diagnosis of metabolic syndrome in obese and overweight adolescents

      ea0037ep122
    • Is there a link between lipid profile and thyroid function modification during somatropinum treatment for GH deficiency in children?

      ea0037ep123
    • Haploinsufficiency of the SHOX gene associated with mosaicism 45,X/46,XY with chromosome Y ring as causes of delayed growth and puberty

      ea0037ep124
    • Endocrine and metabolic profiles in adults with Prader-Willi syndrome

      ea0037ep125
    • Diagnostic value of amino-terminal peptide of type I procollagen when retesting GH deficiency in the transition period

      ea0037ep126
    • Precocious puberty in the obese child as a diagnostic challenge

      ea0037ep127
    • Is thyroid function related to masked hypertension?

      ea0037ep128
    • Effect of metformin on sex steroid levels in postmenopausal type 2 diabetic patients

      ea0037ep129
    • Serum prolactin levels in transgender persons before and during cross-sex hormonal treatment

      ea0037ep130
  • Reproduction, endocrine disruptors and signalling
  • • 25-Hydroxyvitamin D status in elderly patients with Hashimoto[apos]s thyroiditis

      ea0037ep131
    • How much insulin resistance in polycystic ovary syndrome: comparison of HOMA and insulin resistance (Belfiore) index models

      ea0037ep132
    • Surrogate markers of insulin resistance obtained from oral glucose tolerance test in different phenotypes of polycystic ovary syndrome

      ea0037ep133
    • A case of dyskeratosis congenita associated with hypothyroidism and hypogonadism

      ea0037ep134
    • NMDA receptor mediated limbic encephalitis in a woman with mature cystic ovarian teratoma: a case report

      ea0037ep135
    • The impact of bleeding patterns and hormonal contraceptives on migraine headache: a retrospective cross-sectional study

      ea0037ep136
    • Constitutive and inducible regulation of PEPCK isoform genes in human cells

      ea0037ep137
    • Study on the correlation between serum androgens and sexual function in post-menopausal women

      ea0037ep138
    • Increased circulating urocortin-3 levels is associated with polycystic ovary syndrome

      ea0037ep139
    • Implication of non polar phytocomponents of aloe vera gel in management of polycystic ovarian syndrome

      ea0037ep140
    • Abstract unavailable

      ea0037ep141
    • Is idiopathic hirsutism associated with an increase in metabolic disturbances?

      ea0037ep142
    • Prevalence and pattern of menstrual disorders and related factors among Iranian women in reproductive ages: a population based study

      ea0037ep143
    • Testosterone level in men correlates with BMI and cardiorespiratory fitness but is not related to age

      ea0037ep144
    • Analysing by decade, testosterone undecanoate depot injectable does not increase prostate volume: study during up to 7 years on hypogonadic patients

      ea0037ep145
    • Testosterone undecanoate 1000 mg at 3 months did not increased prostatic specific antigen level: January 2015

      ea0037ep146
    • Role of elevated serum adiponectin in delayed puberty of thalassemic patients

      ea0037ep147
    • Prevalence of autoimmune thyroid markers in euthyroid women with polycystic ovary syndrome

      ea0037ep148
    • Stereoselective effects of statins on xenobiotic-metabolising pathways

      ea0037ep149
    • Serum N-terminal pro-B-type brain natriuretic peptide levels detection and cardiac interventricular septum tissue Doppler echocardiographic evaluation of women with polycystic ovary syndrome

      ea0037ep150
    • The effects of endocrine disruptors on the in vitro hormone regulation of rat pituitary

      ea0037ep151
    • Endocrine disruptive effect of plastic byproduct bisphenol A on GH activity

      ea0037ep152
    • A possible link between LH and macrophage migration inhibitory factor levels in polycystic ovary syndrome

      ea0037ep153
    • Analysis of gonadal steroid secretion in the serum of women during ovarian stimulation

      ea0037ep154
    • Lower peripheral fat persists in HIV-infected subjects despite viral suppression in the era of highly-active antiretroviral therapy

      ea0037ep155
    • An audit of prevalence and management of erectile dysfunction and LUTS in a diabetes clinic?

      ea0037ep156
    • Maternal obesity in pregnant rats is associated to increased levels of oestradiol during early postnatal life and altered ovarian follicular development in the offspring

      ea0037ep157
    • Glucagon-like peptide-1 stimulates insulin secretion and then somatostatin secretion in rat islets

      ea0037ep158
    • Treatment with antifungal agents, fenhexamid and cyprodinil, resulted in an increase of cell cycle- and metastasis-related genes in an oestrogen receptor-dependent pathway in cellular and xenografted mouse models with BG-1 ovarian cancer cells

      ea0037ep159
    • Ovarian cancer growth was induced by 2,3,7,8-tetrachlorodibenzo-[rho]-dioxin through the regulation of CYP1A1 gene in an oestrogen receptor-dependent pathway in BG-1 ovarian cancer cells

      ea0037ep160
    • Hormonal disorders in adult women with acne

      ea0037ep161
    • Modulation of the circadian clock by glucocorticoid receptor in H295R cell line

      ea0037ep162
    • An information theoretic approach to GnRH signalling

      ea0037ep163
    • Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities

      ea0037ep164
    • Identification of p53 regulation site on the p27 promoter

      ea0037ep165
    • The influence of late onset hypogonadism on the formation of proinflammatory cytokines imbalance in patients with obesity and type 2 diabetes

      ea0037ep166
    • Palmitic acid enhances TLR4 expression and promotes resistin/TLR4 signalling

      ea0037ep167
    • Heterogeneity of human chorionic gonadotropin (hCG) in commercial preparations of hCG and human menopausal gonadotropin

      ea0037ep168
    • Differential cell cycle control protein profiles characterise bronchial carcinoids sensitive to mTOR inhibitors

      ea0037ep169
    • Influence of mTOR and ERK 1/2 pathways on the IGF1 negative feedback in GH secreting pituitary adenoma cell line

      ea0037ep170
    • Role of TGF[beta]1 in pancreatic neuroendocrine tumour

      ea0037ep171
    • Reduction of growth and lesser utilisation of energy reserves in heroin addicted boys during pubertal development

      ea0037ep172
    • Persistent Mullerian duct syndrome: a case report

      ea0037ep173
    • 47,XYY syndrome and hypogonadotropic hypogonadism: is this coincidence or a diverse spectrum of the syndrome?

      ea0037ep174
    • Endocrine disorders in women with Turner syndrome

      ea0037ep175
    • In vitro effects of aspartic acid, coenzyme Q10 and zinc on sperm function

      ea0037ep176
    • The effect of androgen replacement therapy on platelet aggregation in male patients with isolated hypogonadotropic hypogonadism

      ea0037ep177
    • Visceral adiposity index - new anthropometric marker in women with polycystic ovary syndrome: preliminary reports

      ea0037ep178
    • Evaluation of most common symptoms and findings in Turkish adolescent girls with polycystic ovary syndrome

      ea0037ep179
    • Post load insulin vs fasting levels in prediction of type 2 diabetes in women with PCOS

      ea0037ep180
    • Ameliorated effects of allium sativum against bisphenol A-induced reproductive toxicity in male rats

      ea0037ep181
    • Is serum estradiol really increased in patients with Klinefeler syndrome? Results from a meta-analysis study

      ea0037ep182
    • Relationship between diabetes mellitus type 1 and male reproductive function

      ea0037ep183
    • Serum dihydrotestosterone equivalent levels in women: a new index of hyperandrogenemia

      ea0037ep184
    • Eating habits of women without hormonal contraception depends on menstrual cycle - preliminary report

      ea0037ep185
    • Relationship between polycystic ovary syndrome and platelet distribution width

      ea0037ep186
    • Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL17, IL23, IL33 cytokines in polycystic ovary syndrome

      ea0037ep187
    • Effects of thiouracil compounds on chemically induced rat mammary gland carcinogenesis

      ea0037ep188
    • The role of tailored treatment on conception and pregnancy at patients with insulin resistance

      ea0037ep189
    • Eating pattern does not depend on the menstrual cycle phase in a group of women taking hormonal contraceptives: preliminary reports

      ea0037ep190
    • The PCOS demographic in a dedicated University Hospital Clinic

      ea0037ep191
    • Hypercoagulable overall haemostatic potential is not intrinsically associated with PCOS but worsens with increasing BMI

      ea0037ep192
    • PZ-TR: a novel human luciferase reporter cell line for assessment of thyroid receptor transcriptional activity

      ea0037ep193
    • Evaluation of an automatic referral system for inpatients with hyponatraemia: prompt referral leads to active intervention

      ea0037ep194
    • Klinefelter syndrome: a small sample retrospective analysis

      ea0037ep195
    • Endocrinopathies associated with lithium therapy in an Irish tertiary referral centre

      ea0037ep196
    • The connection between serum prolactin, TSH, and insulin resistance in polycystic ovary syndrome patients

      ea0037ep197
    • The serum AMH/total follicle count ratio is equal in women with and without PCOS

      ea0037ep198
    • Endocrine emergencies as problem in Emergency Department 6 years observation including over 200 000 admissions

      ea0037ep199
    • ThyrART: association of embryo quality and reproductive outcome after IVF with thyroid autoimmunity

      ea0037ep200
    • Association of rs1800790 in fibrinogen beta polypeptide chain gene (FGB) with endometrium in Iranian women

      ea0037ep201
    • A haplotype of the EPCR gene is associated is a candidate risk factor for uterine myomas in Iranian women

      ea0037ep202
    • Sexual function in women with polycystic ovary syndrome

      ea0037ep203
    • Salivary cortisol response to psychological stress in late adolescent and young women: impact of menstrual irregularity, hirsutism, and hyperandrogenaemia

      ea0037ep204
    • Leptin and insulin resistance: impact on gonadal function in Algerian obese women

      ea0037ep205
    • PCOS and thyroid disorder

      ea0037ep206
    • Biochemical and hormonal parameters in patients presenting with hirsutism

      ea0037ep207
    • An endocrine disrupting chemical, bisphenol A: could it be associated with sex differentiation in brain regarding to transsexuality?

      ea0037ep208
    • The commonly used plasticisers (bisphenols and phthalates) as endocrine disrupting chemicals in healthy women and women with polycystic ovary syndrome

      ea0037ep209
    • Serum gonadotropins secretion is not reduced with advancing age in HIV-infected females: results of a case-control study in menopausal women

      ea0037ep210
    • Association between Apa-I polymorphism in the vitamin D receptor gene and metabolic syndrome in polycystic ovary syndrome

      ea0037ep211
    • XbaI and PvuII oestrogen receptor alpha gene polymorphism and Y chromosome deletions in infertile vs fertile men

      ea0037ep212
    • The impact of adiposity on serum anti-Mullerian hormone in normal and overweight women with decreased ovarian reserve

      ea0037ep213
    • Clinical characteristics of different phenotypes of polycystic ovary syndrome

      ea0037ep214
    • Effects of oral contraceptives on the periodontium

      ea0037ep215
    • Relationship between androgen levels and markers of endothelial dysfunction in men with type 2 diabetes

      ea0037ep216
    • Subclinical hypothyroidism in patients with polycystic ovary syndrome

      ea0037ep217
    • Subclinical hypothyroidism in young women with polycystic ovary syndrome

      ea0037ep218
    • The relationships of bisphenol A levels with leptin and adiponectin in premenopausal women

      ea0037ep219
    • Characteristics of body composition in different phenotypes of women with polycystic ovary syndrome

      ea0037ep220
    • Copy number variations in the X chromosome of Klinefelter syndrome

      ea0037ep221
    • Circulating levels of FSH in men are genetically determined: study of the combined effect of polymorphisms in FSHR and FSHB genes

      ea0037ep222
  • Calcium and Vitamin D metabolism
  • • Development of an ELISA for the measurement of free 25OH vitamin D

      ea0037ep223
    • Brown tumour in a patient with ectopic mediastinal parathyroid adenoma: a case report

      ea0037ep224
    • Influence of vitamin D binding protein and C3-epimer on accuracy of 25OH vitamin D ELISA assays

      ea0037ep225
    • Pitfalls in the interpretation of bone turnover markers in liver transplantation

      ea0037ep226
    • The evaluation of oxidative status via the measurements of total oxidant status, total anti-oxidant status, ischaemia-modified albumin and oxidised-low density lipoprotein in patients with vitamin D deficiency

      ea0037ep227
    • Vitamin D status among the doctors in a tertiary referral centre in Kerala

      ea0037ep228
    • The relationship between vitamin D and non-alcoholic fatty liver disease in type 2 diabetic Egyptian patients

      ea0037ep229
    • Study of vitamin D levels in adult males in Dakahlia Governorate

      ea0037ep230
    • Is there a relationship between neutrophil/lymphocyte ratio and vitamin D levels in individuals over 65 years of age?

      ea0037ep231
    • Relationship among plasminogen activator inhibitor-1, bone mineral density, metabolic and bone turnover markers in postmenopausal women with type 2 diabetes mellitus

      ea0037ep232
    • Different influences of physiological and medicamentous hyperprolactinaemia on calcium metabolism in rats - experimental study

      ea0037ep233
    • The effects of maternal iron status on infant fibroblast growth factor-23 and mineral metabolism

      ea0037ep234
    • Vitamin D and seasonal variation among Greek female patients with osteoporosis

      ea0037ep235
    • Is vitamin D receptor gene polymorphism TaqI effect the occurrence and subtype of Hashimoto[apos]s thyroiditis?

      ea0037ep236
    • Relation of vitamin D receptor gene polymorphism FOK-I in subtype of Hashimoto[apos]s thyroiditis

      ea0037ep237
    • Effect of supplementation with vitamin D and calcium to excessive suppression of bone metabolism during antiresorptive therapy

      ea0037ep238
    • Familial hypercalcaemic hypocalciuria in a woman with Graves[apos] disease: a case report of mistaken identity

      ea0037ep239
    • Recalcitrant hypocalcaemia in a patient with post-thyroidectomy hypoparathyroidism and roux-en-y gastric bypass

      ea0037ep240
    • Hypovitaminosis D in pregnancy: can the Mediterranean paradox be explained? A systematic review

      ea0037ep241
    • Association between BMI and femoral neck bone mineral density in post-menopausal women: analysis of NHANES cross sectional data 2008-2012

      ea0037ep242
    • The response to teriparatide of a patient with [beta]-thalassemia and multiple endocrine complications

      ea0037ep243
    • Quick PTH improves the cure rate of minimally invasive surgery in patients with primary hyperparathyroidism and preoperative localized parathyroid adenoma

      ea0037ep244
    • A rare cause of increased bone mineral density in adulthood: autosomal dominant osteopetrosis

      ea0037ep245
    • Hypocalcaemia due to 22q11.2 deletion syndrome diagnosed in adulthood

      ea0037ep246
    • Clinical and biochemical response to denosumab in a young adult patient with craniofacial fibrous dysplasia

      ea0037ep247
    • Hypophosphataemic rickets: two unrelated Mexican female cases and review of the literature

      ea0037ep248
    • Analytical evaluation of a new fully automated immunoassay for the quantification of 1,25-dihydroxyvitamin D

      ea0037ep249
    • High offset point for normocalcaemic secondary hyperparathyroidism due to vitamin D deficiency

      ea0037ep250
    • Low bone mass in Sheehan[apos]s syndrome: prevalence and management

      ea0037ep251
    • Comparison of the pre-operative and post-operative haemogram parameters of the patients with primary hyperparathyroidism

      ea0037ep252
    • TSH and free-T3 correlate negatively and independently with bone mineral density in adults with subclinical hypothyroidism

      ea0037ep253
    • Vitamin D deficiency in patients with autoimmune thyroiditis

      ea0037ep254
    • PTH 1-34 replacement therapy in post-surgical hypoparathyroidism: preliminary results from the 6-month follow up study

      ea0037ep255
    • Vitamin D is essential for the musculoskeletal health, its effect being independent of age, menopause or PTH level: our study aims to find the threshold of 25OH-D, suggestive for osteoporosis

      ea0037ep256
    • Diabetes mellitus type 1

      ea0037ep257
    • Primary hyperparathyroidism with negative pre-operative imaging: a review of current and emerging localisation modalities

      ea0037ep258
    • Rapid and profound decrease in resorbtion markers preceded early and profound increase in BMD after successful surgery in osteitis fibrosa cystica

      ea0037ep259
    • Primary hyperparathyroidism in pregnancy: a case series

      ea0037ep260
    • Comparative effectiveness of biphosphonates and parathyroidectomy in osteoporosis related to primary hyperparathyroidism

      ea0037ep261
    • Investigating the bone metabolic parameters and serum 25-hydroxyvitamin D levels in male patients with asymptomatic hyperuricemia

      ea0037ep262
    • Clinical outcome of patients with parathyroid gland carcinoma - single centre experience

      ea0037ep263
    • Measuring BMD at forearm aids in diagnosing osteoporosis and identifies more patients for surgery in asymptomatic primary hyperparathyroidism

      ea0037ep264
    • Severe refractory hypocalcaemia associated with osteoblastic metastatic breast carcinoma

      ea0037ep265
    • Osteoporotic fracture risk in menopausal women with obesity

      ea0037ep266
    • Evaluation of the effect of bisphosphonate therapy of postmenopausal osteoporosis using Dolga index

      ea0037ep267
    • Patients with new onset diabetes after liver transplantation have higher sclerostin levels that tend to decrease after an oral glucose tolerance test

      ea0037ep268
    • X-linked hypoparathyroidism: an Indian kindred!

      ea0037ep269
    • A case of a mitochondrial myopathy with multiple endocrinopathy

      ea0037ep270
    • Vitamin D receptor genotypes and their association with the 5-year changes in bone mineral density in Spanish postmenopausal women

      ea0037ep271
    • Cinacalcet remains effective in primary hyperparathyroidism after 4 years of treatment

      ea0037ep272
    • Bone mineral density evolution after parathyroidectomy in patients with primary hyperparathyroidism

      ea0037ep273
    • Effect of the inhibition of a cholesterol membrane transporter on vitamin D absorption: a double-blind randomised placebo-controlled study

      ea0037ep274
    • Acquired FGF23 resistance: the primacy of parathyroid hormone over fibroblast growth factor 23 in renal phosphorus handling

      ea0037ep275
    • Lower levels of vitamin D as a predictor of reduced muscle strength in moderately obese postmenopausal women

      ea0037ep276
    • Evaluation of calcium and vitamin D disorders: case report of two patients

      ea0037ep277
    • 25-OH vitamin D: a predictor of clinical outcomes in primary hyperparathyroidism

      ea0037ep278
    • The diagnostic value of parathyroid hormone washout in primary hyperparathyroidism patients with negative or unequivocal 99mTc-MIBI results

      ea0037ep279
    • Proximal femur strength, cortical thickness and bone structure in Klinefelter syndrome

      ea0037ep280
    • 18F-fluorocholine as PET tracer to localize the dominant source of PTH in a patient with X-linked hypophosphataemia and hyperparathyroidism

      ea0037ep281
    • A prospective study on juvenile primary hyperprathyroidism population

      ea0037ep282
    • Outcome of subtotal parathyroidectomy in patients with renal hyperparathyroidism

      ea0037ep283
    • Asymptomatic pulmonary cement embolism after vertebroplasty: a case report

      ea0037ep284
    • Low extracellular sodium promotes adipogenic commitment of human mesenchymal stromal cells: a novel mechanism for chronic hyponatremia-induced bone loss

      ea0037ep285
    • Thalassemia-induced osteoporosis and bisphosphonate treatment: a systematic review and meta-analysis

      ea0037ep286
    • Bones in pseudohypoparathyroidism type 1a

      ea0037ep287
    • Clinical risk factors for osteoporosis in type 1 diabetes

      ea0037ep288
    • Glucocorticoid induced osteoporosis: can we do more to prevent it?

      ea0037ep289
    • Barakat syndrome: an uncommon cause of hypocalcaemia

      ea0037ep290
    • The diagnostic value of parathyroid hormone washout after fine-needle aspiration in patients with primary hyperparathyroidism

      ea0037ep291
    • Relationship between vitamin D supply and healing in patients with hip fracture

      ea0037ep292
    • An oral high dose of cholecalciferol restores vitamin D status in deficient postmenopausal HIV-1 infected women independently of protease inhibitors therapy

      ea0037ep293
    • May the polymorphism of low molecular weight protein tyrosine phosphatase modulate metabolic and bone remodelling parameters associated with osteoporosis?

      ea0037ep294
    • Pancreatitis in familial hypocalciuric hypercalcaemia

      ea0037ep295
    • Giant parathyroid adenoma with severe hypercalcaemia: case report

      ea0037ep296
    • Primary hypoparathyroidism is common in adult patients with [beta]-thalassemia and protect patients from osteoporosis

      ea0037ep297
    • Renal calcification in hypoparathyroid patients treated with calcium and vitamin D: can biochemistry help?

      ea0037ep298
    • Parathyroid tissue in ectopic thyroid tissue

      ea0037ep299
    • Anti-diabetic treatment as an additional factor in a FRAX based evaluation of osteoporotic fracture risk

      ea0037ep300
    • A giant parathyroid cyst manifesting with a neck mass and hypercalcaemic crisis

      ea0037ep301
    • Observational study of PTH secretion dynamics in patients with secondary hyperparathyroidism

      ea0037ep302
    • Fragility fractures as the initial manifestation of indolent systemic mastocytosis

      ea0037ep303
    • Evaluation of clinical and biochemical features of patients with atypical parathyroid adenoma: a retrospective study

      ea0037ep304
    • Investigation of the relationship between type 2 diabetes and osteoporosis

      ea0037ep305
    • Intraoperative parathyroid hormone monitoring during parathyroidectomy: description of our clinical experience

      ea0037ep306
    • Hypercalcaemia in patient with primary hyperparathyroidism and acromegaly

      ea0037ep307
    • The value of intraoperative sonographic evaluation of neck in primary hyperparathyroidsm: case report of preoperative double adenoma upgraded to triple intraoperatively

      ea0037ep308
    • Parathyroid hormone therapy for postoperative resistant hypocalcaemia

      ea0037ep309
    • Vitamin D deficiency and bone health in patients with learning disability

      ea0037ep310
    • Primary hyperparathyroidism presented as humeral brown tumor and multiple bone fractures

      ea0037ep311
    • Comparative diagnostic value of ultrasound, ultrasound-guided fine needle aspiration and sestamibi scintigraphy for the correct preoperative localisation of parathyroid adenomas

      ea0037ep312
    • The effects of single high dose vs daily low dose oral cholecalciferol treatment on vitamin D levels and muscle strenght in posmenapousal women

      ea0037ep313
    • Idiopathic hypercalcaemia in pregnancy not due to PTHrP: suggestion for another pathomechanism by genetic defect of 24-hydroxylase

      ea0037ep314
    • The peripheral serotonin, the serum osteocalcin and CrossLaps: the assay in menopausal women

      ea0037ep315
    • Vitamin D deficiency in acutely ill patients

      ea0037ep316
    • The clinical profile of primary hyperparathyroidism: a single centre experience

      ea0037ep317
    • Raised calcium [amp] PTH, not always a primary hyperparathyroidism

      ea0037ep318
  • Diabetes (pathiophysiology & epitemiology)
  • • Insulin receptor substrate 1 and 2 genes polymorphisms are associated with metabolic syndrome but not cardiovascular risk factors in patients with metabolic syndrome

      ea0037ep319
    • Changing of expression of NOD-like receptors in GALT of rats at an experimental diabetes mellitus and pentoxifylline administration

      ea0037ep320
    • Vitamin B12 levels and relationship between B12 and fasting insulin levels elderly patients with metabolic syndrome

      ea0037ep321
    • Does hepatitis C virus (HCV) infection has a role in the pathogenesis of diabetes mellitus in patients with [beta] thalassemia

      ea0037ep322
    • Abstract unavailable

      ea0037ep323
    • The relationship between higher left ventricular mass index and plasma total homocysteine levels in patients with type 2 diabetes mellitus

      ea0037ep324
    • Description of practices related to insulin injection therapy and sharp disposal among patients attending the diabetic clinic, Colombo North Teaching Hospital, Sri Lanka

      ea0037ep325
    • Vaccination status and factors affecting vaccination among diabetics

      ea0037ep326
    • Prevalence of orthorexia in diabetic patients

      ea0037ep327
    • Metabolic control in patients with 1 diabetes mellitus associated with depression

      ea0037ep328
    • Trends in diabetic ketoacidosis presentations at a major rural referral centre in Australia

      ea0037ep329
    • Clinical characteristics in patients with type 2 diabetes mellitus: a cohort study

      ea0037ep330
    • The influence of actual and retroactive T2DM regulation on duration of hospital stay and clinical outcome of patients suffered from NSTEMI/STEMI

      ea0037ep331
    • Serum apelin, salusin-[alpha] and salusin-[beta] levels in type 2 diabetes mellitus and hypertension

      ea0037ep332
    • Variability of anthropometric, echocardiographic and biochemical indices with comorbidity pathology - essential hypertension and type 2 diabetes

      ea0037ep333
    • Salt addition and the risk of type 2 diabetes mellitus: a case-control study

      ea0037ep334
    • Relationship between adiponectin and anthropometric parameters, insulin resistance and transaminase levels in patients with nonalcoholic fatty liver disease and type 2 diabetes

      ea0037ep335
    • Diabetic gallbladder, dyspepsia and metabolic effects

      ea0037ep336
    • Tumour necrosis factor-[alpha] and insulin resistance in patients with nonalcoholic fatty liver disease in combination with type 2 diabetes mellitus

      ea0037ep337
    • Pancreatogenic diabetes

      ea0037ep338
    • Vitamin D level in impaired fasting glucose and impaired glucose tolerance (prediabetic) patients

      ea0037ep339
    • Effects of H. pylori eradication on metabolism and body weight in obese and non-obese patients

      ea0037ep340
    • Discrepancies between the glycosylated haemoglobin based criteria and glucose based criteria for diagnosis of diabetes and pre-diabetes

      ea0037ep341
    • Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor-[gamma] mutation, H449L

      ea0037ep342
    • Irisin plasma level is connected with the android adipose tissue deposit

      ea0037ep343
    • The GH treatment results in the increase of irisin concentration in plasma

      ea0037ep344
    • Acquired partial lipodystrophy is associated with increased risk for metabolic complications

      ea0037ep345
    • Association between +276 G[gt]T polymorphism of the adiponectin gene (ADIPOQ) and insulin resistance in Ukrainian patients with type 2 diabetes mellitus (T2DM)

      ea0037ep346
    • Vitamin D level in diabetic retinopathy

      ea0037ep347
    • Abnormalities in glucose metabolism are present in HCV/HIV co-infected patients with severe liver fibrosis even in the absence of diabetes

      ea0037ep348
    • Gamma glutamyl transferase and C-reactive protein in type 2 Saudi diabetic patients in relation to management modality and components of metabolic syndrome

      ea0037ep349
    • The prevalence of metabolic syndrome in patients with diagnosed type 2 diabetes

      ea0037ep350
    • Insulin-induced lipohypertrophy diagnostics in diabetic patients: subcutaneous fat ultrasonography

      ea0037ep351
    • Unvisible lipohypertrophy and diabetes compensation: is there link?

      ea0037ep352
    • Glycoregulation during pregnancy

      ea0037ep353
    • Smoking habits and the risk of type 2 diabetes mellitus in women

      ea0037ep354
    • Optimal glycaemic control and a low rate of micro and macrovascular complications in patients with HNF1A-MODY treated in a dedicated tertiary referral centre

      ea0037ep355
    • Plasma omentin-1 level does not change in the first trimester in women with gestational diabetes mellitus

      ea0037ep356
    • The role of TCF7L2 polymorphism in the development of type 2 diabetes in subjects with metabolic syndrome

      ea0037ep357
    • Serum irisin level increases throughout the gestational period and it does not play role in development of gestational diabetes mellitus

      ea0037ep358
    • Gestational diabetes mellitus may associate with atherosclerosis due to high mean platelet volume which is a determined of platelet function

      ea0037ep359
    • Role of nitrosative and oxidative stress on the development of gestational diabetes mellitus and their effect in GDM placenta

      ea0037ep360
    • Dynamic thiol/disulfide homeostasis in patients with newly diagnosed type 2 diabetes mellitus

      ea0037ep361
    • The growth patterns in children born to mothers with gestational diabetes mellitus

      ea0037ep362
    • Insulin resistance is associated with larger thyroid volume in adults with type 1 diabetes

      ea0037ep363
    • Rate of impaired glucose regulation in outpatient care

      ea0037ep364
    • The prevalence of diabetes and associated risk factors among adult population in a Turkish population (Trabzon city)

      ea0037ep365
    • Diabetes mellitus in patients with rheumatoid arthritis

      ea0037ep366
    • Correlation between fasting plasma glucose levels and HbA1c for diagnosis of prediabetes and diabetes: the 2011 Korea National Health and Nutrition Examination Survey

      ea0037ep367
    • Blood lead is associated with impaired fasting glucose in middle-aged population: the 2008-2011 Korean National Health and Nutrition Examination Survey

      ea0037ep368
    • The state of superoxidedismutase activity as marker of oxidative stress in patients with impaired glycaemic states

      ea0037ep369
    • Comparison between aldosterone and renin measurement by chemiluminescent immunoassay and RIA for the diagnosis of primary aldosteronism

      ea0037ep370
    • Listening to the patient[apos]s story: a qualitative approach to pre-gestational diabetic pregnancy

      ea0037ep371
    • Biorhythms of contrinsular hormones in pregnant with type 1 diabetes receiving insulin with pump therapy and multiple injections

      ea0037ep372
    • Higher glucose levels and prevalence of prediabetes in patients with autoimmune thyroiditis

      ea0037ep373
    • Effectiveness of A[beta] classification of diabetes prone to ketosis in real clinical practice

      ea0037ep374
    • Evaluation of quality indicators in hospital discharge reports in diabetic patients from an Internal Medicine Service: are we doing a good clinical practice?

      ea0037ep375
    • Gonadal hormone regulates the expression MATE1 and OCT2 in type 2 diabetes mice

      ea0037ep376
    • The clinical effectiveness of screening for gestational diabetes mellitus in primary vs secondary care: results of a randomised controlled trial

      ea0037ep377
    • Risks of having gestational diabetes in the future for mothers and their offspring

      ea0037ep378
    • Maintenance of risk reduction during 3-year follow up in prevention of type 2 diabetes by lifestyle intervention in primary health care setting: Diabetes in Europe Prevention using Lifestyle, physical Activity and Nutritional intervention (DE-PLAN) project

      ea0037ep379
    • Discrepancies between the HbA1c criteria and glucose-based criteria for diagnosis of diabetes and pre-diabetes

      ea0037ep380
    • The correlation of serum ferritin and diabetes, glucose control or insulin resistance, related or not?

      ea0037ep381
    • Impact of ACE gene polymorphism on preeclampsia development and insulin resistance aggravation in pregnant women with type 1 diabetes mellitus

      ea0037ep382
    • Mechanisms of development of carbohydrate metabolism disturbances in acromegalic patients depending on treatment

      ea0037ep383
    • TRAIL downregulates endothelin 1 and upregulates superoxide dismutase 1 in human aortic endothelial cells under pro-atherorgenic conditions

      ea0037ep384
    • Surgical trauma and insulin resistance

      ea0037ep385
    • A case of maternally-inherited diabetes with deafness

      ea0037ep386
    • Association of neutrophil to lymphocyte ratio with different glucose metabolism status

      ea0037ep387
    • Contribution of glucose variability to HbA1c levels in patients with type 1 diabetes

      ea0037ep388
    • Increasing NAD+ availability in skeletal muscle to augment energy metabolism

      ea0037ep389
    • Prepregnancy care: an opportunity not to be missed

      ea0037ep390
    • Lipoprotein associated phospholipase A2 was not associated with diabetic rethinopathy

      ea0037ep391
    • Concentrations of the vitamin D metabolite 1,25(OH)2D and its relationship to inflammatory and metabolic parameters in diabetes type 2

      ea0037ep392
    • Abstract unavailable

      ea0037ep393
    • 10 years of improving outcomes for women with pre-gestational diabetes

      ea0037ep394
    • Unawareness hypoglycaemia in patients with type 1 diabetes mellitus: prevalence and predictive clinical characteristics

      ea0037ep395
    • Glycaemic control is comparable in patients with or without significant hepatic fibrosis as assessed by NAFLD fibrosis score

      ea0037ep396
    • Targeting optimal metabolic parameters in type 1 diabetes and concomitant coeliac disease: an extra challenge

      ea0037ep397
    • Modulation of metabolic parameters and antioxidant enzymes in diabetic ageing female rat brains: beneficial role of metformin

      ea0037ep398
  • Diabetes (complications & therapy)
  • • Obstructive sleep apnoea and type 1 diabetes mellitus

      ea0037ep399
    • Efficacy of sitagliptin added on to intensive insulin therapy in type 2 diabetic patients

      ea0037ep400
    • Abstract unavailable

      ea0037ep401
    • Is vitamin D a predictor of premature atherosclerosis in type 2 diabetic patients?

      ea0037ep402
    • Long-term use of insulin pump vs pens in treating young children with type 1 diabetes

      ea0037ep403
    • Effect of liraglutide 1.8 mg in patients with non-controlled type 2 diabetes mellitus at an endocrinology clinic: LIED-2 Study

      ea0037ep404
    • Correlation of left ventricular hypertrophy and left ventricular diastolic dysfunction with HbA1c in newly diagnosed type 2 diabetics

      ea0037ep405
    • The frequency of fall and risk factors in elderly patients with type 2 diabetes

      ea0037ep406
    • Factors influencing prognosis in patients hospitalised with diabetic ketoacidosis

      ea0037ep407
    • Microalbuminuria in children and adolescents with type 1 diabetes mellitus: predictive factors

      ea0037ep408
    • Assessment of iodine status and thyroid structure changes in a cohort of patients with diabetes mellitus type 1 and comorbid chronic kidney disease in Belarus

      ea0037ep409
    • Association of dyslipidaemia, chronic kidney disease and hypertension with carotid atherosclerosis in patients with type 2 diabetes mellitus

      ea0037ep410
    • Validation of self-reported oral health measures for predicting periodontitis among adult Filipinos with type 2 diabetes mellitus

      ea0037ep411
    • The effect of MCP-1 A-2518G polymorphism on development of diabetic coronary artery disease

      ea0037ep412
    • Phenotype-directed personalisation of therapy in type 2 diabetes mellitus patients and criteria of prescription

      ea0037ep413
    • Glucogenic hepatopathy: a rare and underdiagnosed condition in type 1 diabetes

      ea0037ep414
    • Assessment of dependence of the hypoglycaemic episodes frequency on gender factor

      ea0037ep415
    • Comparison of umbilical cord ghrelin concentrations in full-term pregnant women with or without gestational diabetes

      ea0037ep416
    • The relationship between metabolic syndrome and albuminuria in patients with type 2 diabetes mellitus

      ea0037ep417
    • Achievement of recommended glucose, lipid, and blood pressure targets in patients with type 2 diabetes mellitus

      ea0037ep418
    • Staphylococcus aureus nasal carriage and related risk factors in diabetic foot patients

      ea0037ep419
    • The role of fetuin A as a biomarker of atherosclerosis and its relation to type 2 diabetes

      ea0037ep420
    • Association of plasma fetuin-A levels and peripheral vascular disease in type 2 diabetic patients

      ea0037ep421
    • Glycaemic variability in pregnant women with gestational diabetes

      ea0037ep422
    • Sexual function in women with diabetes at a Diabetes Care Unit

      ea0037ep423
    • Particular characteristics of breath during night sleep in type 1 diabetes patients

      ea0037ep424
    • Obstructive sleep apnoea, incident type 2 diabetes mellitus, and cardiovascular risk

      ea0037ep425
    • Simultaneous pancreas-kidney transplantation effect on stabilisation/progression of diabetic complications in patients with type 1 diabetes

      ea0037ep426
    • Influence of diabetic polyneuropathy on the severity of pain in patients with osteoarthritis of the knee joints and type 2 diabetes mellitus

      ea0037ep427
    • Lixisenatide clinical experience on patients with type 2 diabetes and obesity in Endocrinology Offices

      ea0037ep428
    • Nonglycemic effects of incretins in patients with long history diabetes type 1 and chronic kidney disease

      ea0037ep429
    • COMMODITY12 telemedicine system is effective in primary care setting in patients with type 2 diabetes

      ea0037ep430
    • Microangiopathic complications in latent autoimmune diabetes in adults: relationship with thyroid autoimmunity

      ea0037ep431
    • Evaluation series on safety and efficacy of nutritional supplements (ESSENS) in newly diagnosed hyperglycaemia